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Data management is the art of collecting, curating and properly storing
data. It usually represents the introductory step to data analysis, which
is the art of extracting meaningful results out of the high quality datasets
obtained in the previous phase. Notwithstanding these two disciplines are
commonly perceived as two faces of the same coin, they are in fact devoted
to two consecutive but sharply separated tasks.
The work hereby described encompasses both these arts, applied in two
different context: data management within the FP7 EU project NU-AGE
(Santoro et al. 2014) and data analysis on the mtDNA data produced by
the GEHA project (Franceschi et al. 2007a). NU-AGE aim is to assess if
a fortified diet, tailored on elderly’s needs, may be involved in modeling
the aging process. GEHA, on the contrary, focused on understanding the
genetic determinants of longevity.
Both studies require an holistic approach to the data to reach meaningful
results: longevity is well known to be a complex phenotype, where many,
possibly independent, factors play a role in determining the final outcome.
Systems biology represents the corner stone around which all analysis should
be planned and developed.
1.1 systems biology of aging
Aging is characterized by a progressive decrease in the fitness of intercon-
nected physiological systems at all the levels of physiological organization,
from single molecules up to the entire organism. A strong relationship has
been highlighted between chronic, low level inflammation and aging, a con-
dition named "inflammaging" (Cevenini et al. 2013; Franceschi et al. 2000,
2007b). Inflammatory mediators involved in this condition was proposed as
the "common soil" where age-related pathologies may develop and flourish
(Blagosklonny et al. 2009; Salvioli et al. 2013). If from one side inflam-
maging can be considered a physiological phenomenon, it is also true that
it can rapidly become detrimental if the process goes out of control (De
Martinis et al. 2006), causing an excess of local and systemic inflammatory
response. Tackling inflammaging can thus be considered a priority, repre-
senting an effective strategy to reduce the inflammatory status, a striking
risk factor for elderly people, slowing down the development of all those
harmful processes that have in the inflammatory response their main patho-
genesis. Building mechanistic mathematical models describing how biolog-
ical systems interact and eventually allow for the establishment of inflam-
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maging, in response to internal and external stimuli altogether, will help in
further dissect the mechanism behavior and possibly help to define effective
interventions to counteract the chronic inflammation (Cevenini et al. 2008;
Rattan 2014).
The modeling of the NF-κB pathway represents an outstanding example
of this working hypothesis, where not only models help in fully understand
pathways but also suggest were succeeding experiments should be aimed
at (Basak et al. 2012; Tieri et al. 2012). In fact, while the original scope of
the work by Basak et al. was to comprehend the roles different IκB isoforms
play in the temporal response to inflammatory stimuli, it also propelled two
other "side" achievements: first, a careful revision of the literature available
on the topic, done to implement the model itself, and second, thanks to
computational sensitivity analyses, the discovery that different degradation
rates of free and bound pools of IκB are part of a cross-regulation mecha-
nisms contributing to the robustness of the system response (O’Dea et al.
2007). Finally, it was also suggested that NF-κB response may also be influ-
enced by intracellular available metabolic information, an hypothesis which
is now under study (Tornatore et al. 2012).
Besides inflammaging, aging also causes the loss of the so-called metabolic
flexibility (DiPietro 2010), the capacity of cells and tissues to adapt them-
selves from lipid oxidation in fasting conditions to the increase of glucose
uptake, oxidation and storage after a meal or in insulin-stimulated condi-
tions (Galgani et al. 2008). Micronutrients imbalance, as well as overnutri-
tion, may affect metabolic flexibility in several ways: glucose excess causes
the production of ROS that in turn increases oxidative stress (Nunn et al.
2009; Ponugoti et al. 2012); Moreover, overnutrition impacts in the capacity
adipose tissue has to cope with lipids in excess, eventually causing lipids ac-
cumulation and lipotoxicity, and may cause cells to fail shifting towards glu-
cose oxidation due to impaired translocation of GLUT4. Metabolic flexibility
is also involved in system-wide metabolism dysregulation, for example in
type-2 diabetes (T2d) (Corpeleijn et al. 2009).
Immunity and metabolism are deeply intertwined partners. Overnutri-
tion, disrupting energy storage and utilization, propels local inflammation
and impairs metabolic function (Hotamisligil et al. 2008), whereas macronu-
trients deficiencies are suggested to hamper the immune response, some-
what removing the fuel needed to sustain it in terms of energy and sub-
strate needed for proper immune defense. A precise, quantitative, mod-
eling of these complex interactions may thus foster the development of a
diet providing the proper nutritional income to avoid igniting any of these
pathological and pre-pathological states (Calçada et al. 2014; Cevenini et
al. 2010).
1.2 the nu-age project
NU-AGE, “New dietary strategies addressing the specific needs of elderly popula-
tion for an healthy aging in Europe", (Berendsen et al. 2014; Santoro et al.
2014) is a FP7 European project that aims to fill the gap caused by the lack
of an integrated approach in the field of nutrition as a mean to contrast, or
at least slow down, inflammaging (Biagi et al. 2012; Claesson et al. 2012;
Franceschi 2007; Jeffery et al. 2013; Ribaricˇ 2012).
Eurostat (http://epp.eurostat.ac.europa.eu) predictions forecast that
the proportion of 65+ people will severely increase in the EU27 (the 27 Mem-
ber States of the European Union) from 17% to 30% by 2060. A similar in-
creasing trend is also predicted for 80+ people, with a 3-fold increase from
21.8 million in 2008 to 61.5 million by 2060. This dramatic rise has direct and
important implications in terms of the health costs countries will be called
to sustain while the proportion of elderly people progressively increases in
the population. Any strategy able to slow down, reduce or, even better,
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postpone the onset of aging-related diseases, thus improving the health of
elderly European citizens, would be warmly welcomed. A good measure
of how EU considers this issue critical can be provided by the fact that the
whole EU Horizon 2020 program for research and innovation funding is de-
voted to increasing of two healthy years the life expectancy of EU citizens,
based on interventions on physical activity and diet.
NU-AGE builds on the outcomes of previous studies focused on ana-
lyzing single nutrients intakes (Bouwens et al. 2009; Guo et al. 2009) and
pushes on to embrace the concept of "whole diet" as a mean of targeting the
metabolism in its entirety and investigate the sophisticated interconnections
that may exists among different nutrients and their impact on metabolism
and, ultimately, to health status.
The project enrolled in total 1250 sex-balanced free living elderly people,
ranging from 65 to 79 years, free of major overt diseases, in 5 European
countries (Italy, United Kingdom, Netherlands, Poland and France). A map
showing the geographical location of each subject is visible in Figure 1 on
the following page. The trial is a 1-year randomized, single blind, controlled
trial with two parallel arms (control vs "diet"). Subjects, after initial char-
acterization, were randomly assigned to each arm in equal number. Five
standardized questionnaires were then administered both before and after
the trial, encompassing the following domains: dietary habits, life-style and
physical activity, health and medication and other relevant data such as the
functional cognitive status. Blood, urine and faecal samples were collected
before and after the trial to allow for:
• the analysis of immune, inflammation, metabolic, genetic and epige-
netic status;
• measures of the intake of sodium, nitrogen, creatinine and potassium;
• definition of microbiota composition.
Furthermore, NU-AGE will take advantage of "omics" analyses such as
transcriptomics, metagenomics and HITChip arrays to investigate to the
deepest possible level the cellular and molecular mechanisms underpinning
the dietary effect and to identify specific nutritional targets in the elderly.
1.2.1 NU-AGE technical infrastructure
NU-AGE will collect (and in part already has) a massive amount of data
that requires particular care to be efficiently exploited. My role within this
project was to help building the technical infrastructure to support the col-
lection process, from designing the data entry interface to validating the
data and building the database and the needed documentation. Indeed, a
nicely set data management plan represents the best achievement a research
project can obtain to ensure long life to its data.
There are 4 tightly interconnected steps to be considered when talking
about data management: data entry and transmission, data validation, data
documentation and data storage. Failing to attain even one of them may
pose the whole project at risk of failing its objectives in the long term. Each
step, however, requires dedicated resources, i.e. databases and graphical
interfaces, which all together can be, and should be, considered as a result
of the project itself, given the amount of time that must be devoted to these
tasks.
These challenges become more difficult to tackle as a function of the num-
ber of involved recruiting centers. NU-AGE, with its 5 recruitment centers
with different backgrounds, was thus in a critical position. Controlling this
risk required a lot of preliminary work to harmonize how information was
collected and the development of ad-hoc solutions to detect and address
inconsistencies in the shortest possible time, to reduce their propagation
within the data.
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Figure 1: Map of the subjects enrolled by NU-AGE. Point width represents the number of subjects
enrolled in each geographical location, data aggregated at municipality level. Map recon-
structed with Google Maps API (https://developers.google.com/maps/) and Basemap (http:
//matplotlib.org/basemap/).
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There is a last issue that, common in most of the data management steps,
becomes predominant in the last one: data security. There is an innate di-
chotomy here: security in first place means that information must be stored
in protected repositories: data are the final result of the millions of eu-
ros spent to obtain them. Second, but first from an ethical point of view,
data must be secured to protect subjects privacy, which is the cornerstone
around which clinical research is based upon. Missing to comply with this
golden rule should represent enough evidence to sustain that involved par-
ties weren’t able to cope with the challenges they were facing, even before
being considered a matter to be discussed by attorneys in a court. NU-
AGE took data security seriously and promoted all the technical and non-
technical precautions to prevent data disclosure, a briefly sum of which you
will see in later chapters.
Unfortunately, it is still too soon to draw conclusions from NU-AGE data.
At the time of writing, a significant part of the data that will constitute the
future database is still in the data entry phase. In spite of this, you will
be able to get from this dissertation at least a feeling of the challenges that
analyzing the data produced by the project will pose, some of which we are
already discussing and, whenever possible, solving.
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While NU-AGE main goal is to understand how the diet will impact on
subjects as a whole, the project is also laying strong foundations for less
"diet-centric" genetics analyses. All subjects will be genotyped with an Il-
lumina OmniExpress chip containing 750K probes, eventually building a
remarkable database describing the european genetic variability, on which
scientific hypotheses may be tested.
1.3.1 Humans as metaorganisms
However, limiting the analysis to a panel of mainly nuclear SNPs such as
those comprised in OmniExpress chips may not be enough. In recent years,
researchers started to think longevity as the result of three separate genet-
ics, reflecting three separate genomes: the nuclear genome (nDNA), the
mitochondrial genome (mtDNA) and the gut microbiome (GM), the last
composed by the whole set of bacteria living inside our gut with their own
set of genes (Garagnani et al. 2014). From this point of view, human be-
ings should be consider not as a single organism, but as a ”metaorganism"
in which three different microbial ecosystems act together in response of
each other and of external stimuli. Moving from the same premises, the
result of the aging process itself should be considerd as the final outcome
of a complex interaction of biological and nonbiological factors, the latter
further subdivided in environmental and stochastic factors. In developing
this thesis we focused our efforts in investigating one of three genomes: the
mitochondrial DNA.
1.3.2 Mitochondria & Mitochondrial genome
In the cell, mitochondria oversee several key functions: they produce energy
in form of ATP by mean of oxidative phosporilation (OXPHOS), they are
involved in most metabolic pathways and in the apoptotic process, of which
they represent the first step through the release of cytochrome-c. Diseases
such as Alzheimer, diabetes and most degenerative diseases, along with
AIDS progression (Hendrickson et al. 2008) seem linked to this organelle.
Finally, ROS production and mtDNA mutagenesis are the two solid links
connecting mitochondria to the aging process (Lagouge et al. 2013), albeit
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Figure 2: Mitochondrial DNA molecule.
recent studies suggested that increase of ROS production merely represents
a consequence of the age-dependent accumulation of mtDNA damage, and
not a cause of aging itself (Kennedy et al. 2013; Shokolenko et al. 2014;
Trifunovic et al. 2004).
1.3.3 Mitochondrial genome
The mitochondrial genome is constituted by a single, circular, chromosome
of 16569 base pairs, present in a variable number of copies in each mitochon-
drion. At the time of writing, there’s a huge debate in the scientific commu-
nity regarding the reference to be used in mtDNA studies (Bandelt et al.
2014), counterposing advocates of rCRS (Anderson et al. 1981; Andrews et
al. 1999), the formerly undisputed reference, to researchers supporting the
adoption of RSRS, a chimera sequence ideally placed at the very top of the
mtDNA phylogenetic tree, as the new standard (Behar et al. 2012). In this
thesis, whenever possible, we choose RSRS as our reference sequence, since
we believe it represents a more "neutral" reference point, being it an ances-
tral rather than a "phylogenetically peripheral" and modern mitogenome
from Europe, a definition that instead perfectly fits rCRS.
Out of the ~1500 genes originally coded by the mtDNA, only 37 are still
present: 12S /16S rRNAs, 22 tRNAs required in mitochondrial protein syn-
thesis and 13 polypeptides belonging to the OXPHOS system (Wallace
2005). The remaining genes progressively moved to the nucleus, probably
to reduce the risk of their degeneration caused by the Muller’s ratchet (Wal-
lace 2007). However, this continuos flow of copies of mitochondrial genes,
some of which are not under selective pressure in the nucleus, is the root
cause of the most debated problem in sequencing and assembling mitochon-
drial genomes: numts (Nuclear Mitochondrial DNA sequences). Numts are
sequences in the nucleus that show a very high similarity to mitochondrial
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sequences and represent a very good explanation for all the misidentifi-
cations suffered by several studies focused on mitochondrial diseases and
phylogeny reconstruction, and should be thus treated with particular care
(Cannino et al. 2007; Hazkani-Covo et al. 2010; M. Li et al. 2012; Picardi
et al. 2012).
1.3.4 mtDNA and aging
The progressive accumulation of mutations in the mtDNA causes an im-
pairment of the energy production, which is in turn contrasted by the cell
increasing the number of mitochondria. At the same time, studies suggest
that mutated molecules do have a replicative advantage on wildtypes (Rear-
don 2002). This phenomena, in combination with the progressive turnover
of older mitochondria, provokes an enrichment of mutated forms due to the
genetic drift. Sooner or later, the fraction of damaged mtDNA will reach a
breaking point where the decrease in energy production causes an increase
in ROS production that drives the cell toward the activation of the apoptotic
process. At the tissue level, this prolonged cell loss will eventually disrupt
functionalities, igniting pathological states (Wallace 2005). Neurodegen-
erative diseases, such as Alzheimer, Parkinson and Huntington syndrome
(Santoro et al. 2010; Yang et al. 2008), as well as sarcopenia (Kujoth et al.
2006), AIDS progression (Hendrickson et al. 2008) and aging (Salvioli et
al. 2008) were all linked to mitochondrial inefficiencies caused by mtDNA
damage. Recent association studies focused on age-related diseases identi-
fied nuclear loci involved in mitochondrial bioenergetics (PPARγ, PGC-1α
and UCPs), strengthening the evidences of a role of mitochondria in these
pathological states (Capri et al. 2013; J. J. Jia et al. 2010; Raule et al. 2014;
Wallace 2005, 2013).
1.3.5 The GEHA study
In recent years, results coming from the GEHA study (Franceschi et al.
2007a; Skytthe et al. 2011) emphasized the role recurrent and sporadic
mtDNA mutations may have in longevity. The project sequenced the con-
trol region of 3000 samples and the complete mtDNA of 1292 samples (646
ultranonagenarians, 646 controls) from subject enrolled in Denmark, Fin-
land, Southern Italy and Greece (Raule et al. 2014). An initial haplogroup-
based analysis detected an association between haplogroups H2 and T2 with
longevity in females, while J2 resulted associated only with males, con-
tradicting previous results (Domínguez-Garrido et al. 2009; Niemi et al.
2003). However, none of these associations reached the significance level
after proper multiple testing correction was applied. To investigate if rare
variants participate in determining longevity, a Rare-Variant association test-
ing for sequencing data (Wu et al. 2011) was performed. Obtained results
proved that the number of non synonymous mutations in mtDNA genes
coding for subunits composing OXPHOS complexes I, III and V significantly
differs between 90+ and controls. Going into details, mutations in complex
I may be beneficial for longevity, while the cooccurrence of mutations on
both complex I and III or on both I and V might be detrimental for lon-
gevity. The really interesting finding of GEHA, until now, is this very last
results: mutations do interact to determine the phenotype (long-lived or
not).
1.3.6 The interacting mitochondrion
As stated above, more than the 90% of the components needed by mitochon-
dria to work are nuclear-encoded. Thus, there’s a tight interplay between
the two genomes, nDNA and mtDNA, to preserve biological function and
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cell activities (Bar-Yaacov et al. 2012; Kenyon et al. 1997; Rand et al. 2004).
This "communication" is bidirectional, with information travelling from the
mitochondrion to the nucleus, and from the nucleus back to the mitochon-
drion. The "channels" through which this communication can take place
are multiple: protein-protein interaction, protein-RNA interaction in the mi-
tochondrial ribosome and nuclear factors-mtDNA recognition sites interac-
tions in the transcription and replication processes (Bar-Yaacov et al. 2012;
Lung et al. 2006; Rackham et al. 2011). It is well established in literature
that keeping these interactions stable and balanced is fundamental for the
cellular homeostatis and even small alterations lead to stress and acceler-
ated aging. However, little is known on how this communication channels
are regulated.
The investigation of epistatic effects such as the ones described above
represented a nearly-impossible challenge (Tranah 2011) until the advent
of NGS techniques and the increase of available computing power. NGS
provoked a steep fall in the cost of obtaining a sequence, both in terms
of money and working time, at the same time skyrocketing the volume
of data to leverage in the analyses. However, as the amount of informa-
tion to process increases, it also mandatory to develop hardware and meth-
ods able to cope with this tremendous amount of data to be processed in
reasonable time. High performance computing (HPC) is now able to reach a
computing power that was not even imaginable some years ago. In partic-
ular, GPU (Graphics Processing Unit) computing is progressively revolution-
izing the field, delivering groundbreaking performances when small but
massively parallel calculations are needed. Indeed, this is the kind of com-
putations required to perform epistasis analysis (Goudey et al. 2013; Pütz
et al. 2013). An important drawback GPU computing has is the complexity
of programming algorithms on these platforms, which requires dedicated –
and complex – programming languages that are difficult to master without a
pure computer science background. Additionally, dedicated and somewhat
expensive hardware is needed, since using off-the-shelf cards may deliver
performances way below those achieved with consumer-targeted CPUs.
It’s from these foundations that we moved to build our approach to in-
vestigate epistasis. As you may have understood by now, GEHA possess all
the data needed to perform this kind of investigation, which may provide
useful insights on the mtDNA role in the longevity mechanism. Methods to
analyze these interaction already exist (Cordell 2002; Emily 2012; Moore
2015; Moore et al. 2014; Ritchie 2015), but we preferred to develop a new
method based on bayesian statistics that, in our opinion, was better suited
to detect these subtle relations, helped in the job by carefully crafted priors,
obtained by analyzing available sequences databases. Still, conducting these
analyses is really complex: even analyzing a handful of mutations requires
to evaluate all the possible interactions among them. Limiting the analysis
to couples, the problem increases quadratically, n2, where n represents the
number of mutations under analysis. For this reason, we initially tested our
method to detect single variants associations in GEHA mtDNA sequences.
We then analyzed all the non synonymous variants at AA level, removing
those position where more than two different AA were found. This expe-
dient allowed us to avoid having the computational problem exploding in
our hands, while retaining a good exploration of the possible epistatic in-
teractions. While results of this pilot study will be explained in details in
the following chapters, we would like to stress since now that this method,
once further optimized in terms of computing time, will be ready to be
used to investigate epistasis in the full set of mtDNA variability discovered
in GEHA, as well as to be exploited to explore the very same phenomena
including nuclear variants, finally shedding a bit of light on the nuclear-
mtDNA crosstalk.
2 A IM OF THE STUDY
Aging and longevity, as well as inflammaging, are complex phenomena re-
quiring high quality data and cutting-edge analyses to be even partially
understood. At the same time, there is a growing necessity to tackle these
problems, given by the fact that they do have a severe impact on people’s
health and, to be blunt, on the costs each country must sustain to maintain
its own population healthy. The aim of this study is to build on previous
knowledge to at least start unraveling the complex net tightly interconnect-
ing these three phenomena, providing both the components needed to solve
the equation: data and analysis methods.
Data will be provided in the context of the NU-AGE study, which aims to
understand the role diet has in regulating the inflammatory status. In partic-
ular, we will design and implement the project data management pipeline.
To be successful, this effort requires to combine several independent but
tightly interconnected parts covering the whole life of the data, spanning
from the very first moment of their creation, the data entry process, to their
long term storage in properly configured and secured databases. Fulfill-
ing these requirements, however, is far from being easy: as we will see, it
requires to mix together completely different backgrounds, ranging from
software programming, to medicine and data documentation, down to web
applications deployment and monitoring. We will also discuss some of the
preliminary data the project has produced, with a particular focus on the
nutrient intakes.
NU-AGE will collect a plethora of data encompassing several different
fields, that will have to be combined together to provide a reliable and
definitive answer to the scientific questions the project is based upon. As
for all intervention studies, a critical part is represented by the evaluation
of the subjects compliance. In our case, this compliance is extremely diffi-
cult to measure: we’re not administering a new drug, we’re administering
a diet that each subject may decline in his or her own way, eventually di-
verging from the expected behavior. Moreover, controls may change their
behavior while enrolled in project in response to external stimuli, adopting
a healthier diet on their own. It is thus fundamental to precisely measure
how each subject was compliant to its branch, to weight its data accordingly.
To address this key need, in this study we will propose a way of obtaining
a reliable index to measure compliance in diet-based intervention studies.
New analysis methods, on the contrary, will be provided in the form
of new approaches to detect and measure the epistatic interaction in mito-
chondrial DNA, an unanimously recognized player in the longevity arena.
These methods, based on entropy analysis and Bayesian statistics, will be
first tested on the GEHA mtDNA sequences to verify if they will be able to
detect the association of single variants to the longevity phenotype, and then
used on the very same sequences to understand the effects that interacting
mutations may have in influencing the aging process, if any. Additionally,
we will begin to pave the way to the analysis of the crosstalk that occurs
between the mitochondrial and nuclear DNA, which was already hypothe-
sized in literature but is yet to be proven. Eventually, we will also see how
the obtained results, if meaningful, may be used to provide a direct feedback
on the probability of a subject of becoming long-lived or not.
As a side topic, we will cover the realization of a pipeline to analyze NGS
data coming from a Ion Torrent PGMTM platform, stimulated by the poor
performances achieved by stock softwares provided by the manufacturer in
calling variants harbored by the mitochondrial DNA, which is well known
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to represent one of the most tough molecule to be sequenced and analyzed
due to its innate peculiarities, such as the widespread presence of poly-n
stretches.
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Different data, languages, systems and programs were used in this PhD
thesis, depending on the specific task to be accomplished.
Different programming languages may be differently suited to deal with
certain type of data, and the same holds for the numerous Relational Database
Management System (RDBMS) now in the wild. Usually, the final choice is
driven by the attempt to reduce the overhead on the analyses due to the
chosen infrastructure, being it a language or a database.
The aim of this chapters is to list and detail all the technologies and infor-
mation used throughout this study.
3.1 data
As its title says, this thesis is pretty much a deep voyage in data management
and analysis. In is thus important to note that the work described in the
following chapters draws fully from years of efforts taken by several people
in mainly two different European-funded project: GEHA (Franceschi et al.
2007a) and NU-AGE (Berendsen et al. 2014; Santoro et al. 2014).
3.1.1 NU-AGE Data
NU-AGE (Berendsen et al. 2014; Santoro et al. 2014) is a FP7 European
project with the main task of understanding if the Mediterranean diet can
influence, and to which extent, elderly’s health. The project recruited 1250
subjects in the age range 65-79, half of which followed a diet specifically
tailored on the elderly’s needs for 1 year.
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Table 1: NU-AGE questionnaires and assays schema
Measurement Time 0 Follow-up 4m Follow-up 8 Time 1
Blood x x
Urine x x
Faeces x x
Anthropometric x x
DEXA-scan x x
Physical Activity x x
Physical Performance x x
Cognitive status x x
General questionnaire x x
Follow-up questionnaire x x x
Dietary intakea x x x x
a Dietary intake at month 4 and 8 is assessed only in participants in the diet group.
Understanding the effect that diet may have on the people’s health is a
topic that clearly falls in the list of problems you must address with a System
Biology approach: hundreds of parameters may play a small but significant
role in this phenotype, and not considering even a small fraction of them
may be detrimental for the study outcome. Moving from this premises, NU-
AGE adopted the most comprehensive panel of questionnaires and assays
that was technically feasible, a schema of which can be seen in Table 1.
As the reader may imagine, the amount of information produced with
this setup is overwhelming: we’re talking about roughly 2000 variables, and
that is just a small part of the whole database, since storing results of the
planned "omics" analyses, such as
• genomics
• lipidomics
• metabolomics
• transcriptomics
• microbiome analysis via deep sequencing
will be the really groudbreaking challenge here.
Details on how we solved the data management problems will follow in
the succeeding chapters.
3.1.2 GEHA Data
GEHA (Franceschi et al. 2007a) aim was to identify candidate genes in-
volved in healthy aging and longevity. The consortium, composed by 24 Eu-
ropean partners and the Beijing Genomics Institute from China, recruited in
5 years 2650 long-lived 90+ sibpairs and 2650 younger, ethnically matched,
controls from 11 European countries, of which DNA and healthy status was
obtained.
While further details about the study setup can be found in the cited
article, for the sake of this thesis it is important to note that UNIBO was
responsible for the mtDNA sequencing of the enrolled subjects, which was
only in part carried out in our lab, with the biggest batch of samples sent
to the BGI for sequencing. In total, GEHA obtained the complete mitochon-
drial DNA sequence for 1292 subjects, subdivided as reported in Table 2 on
the facing page, and ~2500 D-loop sequences equally subdivided in sibs and
controls.
Additionally, a subset of the samples were genotyped with an Illumina
Human OmniExpress chip containing ~730K probes. This batch originally
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Table 2: GEHA sequence divided by Country and Status
Denmark Finland Calabria Greece By Status
Sibs 422 149 66 8 645
Controls 429 146 58 14 647
By Country 851 295 124 22 1292
comprised 370 subjects from Bologna, of which we now have information
about their nuclear variants.
Finally, in 2014 the phenotypical database (Skytthe et al. 2011) was trans-
ferred to a secure server hosted in the UNIBO IT infrastructure. The data-
base contains the questionnaire information gathered from sibs and controls,
with ~200 and ~100 variables respectively.
3.1.3 DbSNP Data
Microarray results are as good as their annotation is sound and updated.
GEHA microarray data dated back to 2011, and the mapping of the variants
could have been changed significantly in this time interval. Thus, before
proceeding with further analyses it was mandatory to update the original
annotations. However, getting fresh data for 700K+ variants is not some-
thing you can do by hand. DbSNP (Sherry et al. 2001) offers a "Batch sub-
mission" system that accepts up to 30.000 rs codes per request and sends
back the updated records after a time that varies between a couple of min-
utes to 24 hours. In our case, using this approach would have meant to chop
our list of variants in 25 batches, submit them separately and then glue the
results back together. Luckily, Ensembl released in 2014 a brand new REST
API (Yates et al. 2014) that allows to query their variants databases (that are
mainly a mirror of DbSNP content) for updated information. We thus built
a small script based on Python Request library (see 3.2.2) to automate this
task, and retrieved the needed information in a couple of hours.
3.1.4 Eurostat Data
Dealing with data flowing in from different European countries poses sev-
eral difficult to answer questions when you merge the information together:
country is, obviously, a confounding factor you must consider when ana-
lyzing the data. But how strong this factor is for longevity? To answer to
this question we used Eurostat public data to estimate the proportion of 90+
subjects in the population of countries participating in the GEHA project.
3.2 programming languages and libraries
Programming languages are the language you can talk to be understood
by a computer. There are many of them, developed in different times and
to address different problems, but they are usually divided in two main
categories: compiled and interpreted. The first approach is well known for its
speed, which is usually order of magnitude faster compared to the second,
while the latter allows for greater flexibility and platform independence (i.e.
Java).
Compiled languages are much faster because the source code is first "com-
piled" in machine language and then interpreted by dedicated hardware or
software at time of execution. This distinction does not exist in interpreted
languages, in which both processes are done on the fly. However, this speed
gap can be partially filled by just-in-time compilation: the code is compiled
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by the interpreted just before execution, with a gain in speed that can even-
tually be considerable, depending on the program itself (Kluger 2008).
3.2.1 Python
The great part of the work described in this thesis was done in Python
(Python Website), a language implemented by Guido van Rossum. Python
is an interpreted, object-oriented language, which is thus interpreted on-the-
fly by the Python Interpreter, usually referred to as CPython. A project,
codenamed PyPy (pypy Website), is now developing a new implementation
of the Python language that contains a Just-In-Time compiler, allowing pro-
grams to run faster and with a lower memory footprint.
Python gained a considerable momentum in many fields, primarily be-
cause of its easiness of use and low learning curve. It has an innate predilec-
tion for strings (thus sequences) processing, making it a top choice adopted
by bioinformaticians all around the world, but also allows to solve most
tasks exploiting dedicated libraries: numerical calculus (Van Der Walt et
al. 2011), data exploration and analysis (McKinney 2010; Pérez et al. 2007),
advanced plotting (Hunter 2007), web development (Django Website) and
biological data management (Cock et al. 2009).
3.2.2 Python Libraries and Packages
For most of the question you pose to it, Python has a library to answer with.
That’s particularly true in the biology/bioinformatics world, thanks to the
growing adoption Python has in these fields. Hereby follows a list of all the
libraries used in this thesis, with a short description for each of them.
BioPython
BioPython (Cock et al. 2009) does all the heavy lifting of reading (a.k.a.
parsing) biological formats such as FASTA, ClustalW or GenBank (Benson
et al. 2013) and interacting with NCBI’s Entrez databases to download var-
ious type of information, i.e. article abstracts, sequences or GEO datasets
(Barrett et al. 2013).
In the context of this thesis, BioPython was used to pre-process GEHA
mtDNA sequences, both at the quality-check step and before starting epis-
tasis analyses.
SciPy
SciPy (SciPy Website) can be seen in two different ways:
• a package grouping together mathematical algorithms and conven-
ience functions based on NumPy (Van Der Walt et al. 2011);
• an ecosystem of open-source Python packages devoted to science, math-
ematics and engineering.
Most of the packages that follow in this list are indeed part of the SciPy
ecosystem, which is every bit as good as the acclaimed R ecosystem.
Pandas
Pandas (McKinney 2010) is a python package that provides two fundamen-
tal parts of the data processing equation:
• proper data structures, to load, filter and slice the data. The most no-
table structure is the DataFrame, that closely resembles a R dataframe;
• highly efficient but basic tools for exploratory analysis, i.e. average,
percentiles, grouping and so on.
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These two parts, merged together, allow for a quick exploration of new
datasets, and provide a solid base for more advanced analyses. Pandas is
build upon numpy (Van Der Walt et al. 2011), a Python library for scientific
computing.
Mathplotlib
Matplotlib (Hunter 2007) , a 2D plotting library, aims to, as stated in the
project website
”make easy things easy and hard things possible”
and usually fulfill this duty in a very elegant way. The library literally puts
the most common plots (i.e. histograms) at the programmer fingertips, and
more complex plots, such as hexbins, just a couple of lines of codes away.
All the scientific plotting contained in this thesis was powered by mat-
plotlib, helped by libraries such as seaborn (Waskom et al. 2014) or basemap
(Basemap Website), to improve plots appearance and for map projections,
respectively.
Scrapy
If you need to extract – or scrape, to use the correct computer science term,
information from a website automatically, Scrapy (scrapy Website) is the
way to go. Python-based, Scrapy is an application framework to crawl web
sites and extract structured data to be later processed for other task, i.e. for
data mining.
The framework allows to build specialized crawlers that, starting from a
set of url base addresses, dive deep in each website, following the links you
instruct them to, selecting only the pieces of information you need and ex-
porting them in an easy to use comma or tab delimited format. It also keeps
track of already visited urls to avoid being stuck in a loophole and can auto-
matically adjust the crawling speed to accommodate both the needs of the
website you’re crawling and the computer you’re running the crawlers on.
If more sophisticate processing and storage is needed, Scrapy can perform
post-processing of the information, in form of pipelines, and directly store
data into databases.
For the scope of this thesis, Scrapy was used to retrieve the Anatomical
Therapeutic Chemical (ATC) nomenclature to validate the ATC codes entered
by NU-AGE recruitment teams in the data entry process.
Requests
Request is, following the author’s claim,
"HTTP for Humans"
In other words, it’s a Python library to perform HTTP requests, the same
type of request any browser, i.e. Firefox or Chrome, does every time you
access a web page.
What’s the reason behind it in science, you may ask. We’re not visiting
web pages, after all! The reason is that Ensembl (Cunningham et al. 2014)
recently released its own REST APIs (Yates et al. 2014) (where API means
Application Programming Interface and REST Representational State Transfer),
eventually overcoming the long standing problem of the lack of supported
APIs for any programming language, with the exception of Perl. REST APIs
are instead language-agnostic, and can be interrogated via any program-
ming language via HTTP request.
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To do a "real life" parallel, you can think about REST APIs as a librarian
you ask for a book (a dbSNP rs code, Sherry et al. 2001). If your request is
semantically correct (you’re asking the right thing at the right address), he
will reply with the book (data encoded in some format, i.e. JSON), or gently
ask you to rephrase your question (something was wrong in your request).
If you ask too many books together, he will gently tell you to come back
later (too many requests together will be blocked).
A more bioinformatics-related example may be the following: you need
to get updated information about a SNP of which you have only the rs code.
You have many ways to do this, but the two main choices are:
• going to the dbSNP website, write the code in the search box, wait
for the result, read throughout the record to find the information you
need, and use it;
• ask to Ensembl the data via the REST APIs, have a program digest the
reply and extract only the information you need, and then use it.
If you need annotations for just a couple of rs codes, both processes are
doable. On the contrary, if you need to update thousands of them there is
really no choice: a programmatic way is the only approach you can follow.
To implement such a script you can use Python Request library to con-
nect to the Ensembl Variation Endpoint, at the URL address "http://rest.
ensembl.org/vep/human/id", and perform a POST request. POST request
are request that asks the server to accept the payload in the message body,
in this case a JSON-encoded list of rs codes, to be processed. The server will
thus process the list of codes and send you back the requested information,
encoded in JSON. You can then decode the data and extract the bits you
need. All these steps can be successfully done in 2 lines of Python code:
1 request = requests.post(endpoint , headers ={"Content -Type":"
↪→ application/json"}, data=json.dumps ({’ids’ : rs_list
↪→ }))
2 variations = request.json()
where line 1 asks for the data (rs codes are contained in the rs_list variable)
and line 2 parses back the JSON contained in the reply to native Python data
structures.
In this thesis Request was used to obtain gene annotations of a set of vari-
ants contained in a OmniExpress Illumina chip containing ~730K probes.
Plumbum
Python has many built-in and external libraries to interact with external
commands and redirect their output, but what makes Plumbum (Plumbum
Website) outshine its competitors is the easiness of use.
Need to launch a complex-and-very-long command? Just shove all the
arguments in the right order inside a list, and you’re ready to go. You need
to launch the same command many times with different arguments? Save
the root command separately and combine it on-the-fly with the arguments
you need each time.
Finally, in a very long pipeline, such as the pipeline we built for NGS
variants calling, it is fundamental to have an exact control on what’s going
on, and this comes down to two things: logging, to have a clear trace of
what happened, and exit code management, to halt the pipeline as soon as
an error occurs, without losing time and resources processing dirty data.
Well, Plumbum make this straight easy.
SQLAlchemy - The Database Toolkit for Python
SQLAlchemy (SQLAlchemy Website) is a Python library to connect to most
DBMS, making easy to load and query data independently from the under-
lining infrastructure. It consists of two main components: the Core and the
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Object Relation Mapper. The Core is a fully featured abstraction toolkit, which
swiftly removes the problem to connect to different database implementa-
tions and allows to map and query Python Objects to database types. At
the same time the Object Relation Mapper, or ORM, allows to associate user-
defined Python Classes to database tables and instances of these classes to
rows in the corresponding tables, taking care of continuously syncing them.
In this way, the programmer can store and retrieve data from the DMBS
without performing additional conversion steps or leaving the comfortable
Python language.
To give you an explicit example of how the ORM allows for such a level of
customization, here is how we defined an object to store information about
each recruiting center:
1 class RecCentre(Base):
2 """
3 Table to store info on Recruiting Centres
4
5 """
6 __tablename__ = ’recruiting_centres ’
7
8 id = Column(Integer , primary_key=True , autoincrement=
↪→ True)
9 cid = Column(Integer , nullable=False) # Center ID
10 name = Column(String , nullable=False)
11 address = Column(String , nullable=False)
12 country = Column(String , nullable=False)
This object is transformed in a SQLite (see 3.3.2 on page 20) table and
instances automatically pushed to the database.
SQLAlchemy was adopted in this thesis to interact with the SQLite data-
base at the basis of our validation pipeline.
3.2.3 IPython Notebook
IPython Notebook (Pérez et al. 2007) can be easily seen as your data best
friend: it allows to combine code execution, documentation, text and image
visualization in a single, easily shareable, page. Notebooks files are text
files you can move around on your computer, send to colleagues to double-
check your analyses, or make freely available on the web, with just a couple
of clicks.
The IPython Notebook Folder of NU-AGE, grouping together all the note-
books used in this thesis, can be seen in Figure 3 on the following page.
Notebooks are denoted by the ".ipynb" extension, while other rows refer to
nested folders, containing both raw data or other notebooks. On the top, you
can see buttons to access the running notebooks, or enable IPython cluster
computing. You can also easily create a new notebook with the dedicated
button.
An example of a running IPython Notebook can be seen in Figure 4 on
the next page. Here you can appreciate IPython uttermost feature: an in-
teractive experience nailing together code development and execution with
image visualization and prompt access to libraries documentation. In the
Figure you can appreciate at the top the code used to plot the violinplot
shown just beneath it and also have a glimpse of how easy is to get help if,
for example, you forget how to invoke a command: just write the command
and append a "?" mark at the end, as shown in the last line, and IPython
will fetch and display the help for you in no time!
All the plotting, and most of the data post processing, in this thesis was
accomplished via IPython Notebooks, each time combining one or more of
the previously described libraries.
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Figure 3: IPython Notebook Folder - Screenshot of a IPython Notebook folder. Files
with extension .ipynb are IPython Notebook, while other entries are fold-
ers containing either Notebooks or data.
Figure 4: IPython Notebook screenshot. On the top we have the code used to pro-
duce the central figure. The last line shows how easy is to obtain com-
mands documentation: append a "?" mark at the end, and IPython will
get it for you, displaying it a dedicated box.
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3.2.4 R
R (R Foundation for Statistical Computing, Vienna 2008) probably rep-
resents the most acclaimed open source programming language for data
exploration and statistics. A great part of its reputation derives from the im-
pressive number of packages available to "easily" analyze the most disparate
data, developed and maintained by scientists, or companies, all around the
world. Accessing these packages is usually straightforward: many, if not all,
of them are stored in the Comprehensive R Archive Network (CRAN, CRAN
Website) and can be downloaded and installed with a single command. On
the contrary, in biology and bioinformatics the reference archive is Biocon-
ductor (Bioconductor Website), which containing hundreds of packages de-
voted to the analysis of high throughput data.
R was initially adopted in this thesis for the pre-processing and analysis
of raw data coming from the Ion Torrent platform. However, used to the
way higher flexibility of Python, we abandoned R after some initial test and
moved the analysis to the IPython platform.
3.3 databases and web interfaces
Properly and efficiently store data is the first step to easy processing and
advanced (and useful!) analyses.
There is no catch-all answer to which system should be adopted: the fi-
nal decision must carefully weights the kind of data you’re storing and the
overhead you can sustain to provide a higher performance storage back-
end. Sometimes, a complex Database Management System coupled with an
advanced web interface represents the way to go, in other cases a text file is
more then enough to cope with the problem.
3.3.1 Text files
The reader may be disappointed to find text files within a section entitled
"Databases and Web Interfaces". When talking about databases, the imagi-
nation immediately skyrockets to extremely complex systems with terabytes
of data ready to be queried with a single click. Sorry to say, this may hold
strong in Google’s world, but biology, with some notable exception (i.e. high
throughput raw data, image processing, and so on), usually flies at a much
lower altitude. We’re not dealing with "big data" here.
That’s the reason why a text file can be enough to store whole databases
and share subsets of them. The VCF Format (VCF Format Specification
website), the mainstream format to store variants identified via Next Gen-
eration Sequencing (NGS), is a text file format. You can compress it to save
space, but it remains a (very well designed) text-based format. When several
people need to access the same resource at the same time, or the curator fre-
quently updates the data, that’s the case in which something more advanced
is needed, and databases kick in.
There is also an innate benefit in text files: they are just - as the name
says - plain old easy text files: even in a very distant future, a reader for this
format will exist, probably the grandson of the notepad installed by default
in all your computers. So, a scientist needing your data in 10 years from
now will have no problem in reading them. If the same data are locked in
a proprietary abandoned file format, that information would be lost. Think
about it! Always use the easiest and most standardized format you can
afford for your data.
This quite long introduction to say that most of the data used in this thesis
were, at some point of the chain, contained in text files. NU-AGE pipeline
for data management includes steps in which data are sent in text files: it’s
indeed the main format we used to send data from recruiting centers and
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labs to the central database. GEHA sequences were in FASTA format, that’s
again a text-based format, while genotypes were stored in PLINK (Purcell
et al. 2007) MAP and PED formats, and, imagine what? Text-based formats
again!
3.3.2 SQLite
SQLite, citing the official website is
a software library that implements a self-contained, serverless, zero-configuration,
transactional SQL database engine
In a nutshell, SQLite provides you with a fully functional relational data-
base within a single file. Advantages are striking: you can have your data
stored in a database supporting many SQL queries without the overhead of
running a DBMS on a dedicated server and losing time configuring count-
less configuration files. This comes with the price of no concurrent access -
only a single person or process can access the file at once - and limited sup-
port to some SQL constructs. In conclusion, SQLite can be seen as a good
compromise between text files and more complex DBMS.
For the scope of this thesis, SQLite was used to implement a small data-
base to store information about NU-AGE to empower tracking and manage-
ment of data failing the validation checks. You can easily convince yourself
how this was the ideal situation to adopt SQLite: no need for concurrent
access - a single process writes and reads the data - and for complex SQL
constructs (i.e. certain kind of joins SQLite doesn’t support).
3.3.3 PostgreSQL
PostgreSQL (PostgreSQL Website) (a.k.a. Postgres) is an Open Source DMBS
with more than 15 years of active development. It supports most of the
SQL:2011 standard, is ACID-compliant and allows for complex SQL queries
with indexing methods not available in other implementations. It also has
a particular focus on scalability, with latest version supporting database
replication to reliably share the workload on multiple servers.
In this thesis, Postgres was used as database for LabKey (see 3.3.5), a data
integration platform we deployed to address NU-AGE data management
needs.
3.3.4 Dbnp
The "Nutritional Phenotype database" (Dbnp) (Van Ommen et al. 2010) is
an open source effort to produce an application suite to store biological
studies. Although, as the name suggests, it was designed to store nutrition-
related data, it’s module-based architecture allows for a very high degree
of flexibility, allowing it to deal with other types of information such as
phenotypical and omics data.
An instance of this application was (and is) used for long term storage of
NU-AGE’s data, hosted at the TNO, The Netherlands, a NU-AGE partner.
3.3.5 LabKey
LabKey (Nelson et al. 2011) represents one of the best examples of plat-
forms for data sharing and scientists’ collaboration. Implemented in Java,
Labkey runs on multiple platforms (Windows, OS X and Linux), and re-
quires:
• Apache Tomcat to run the web application;
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• PostgreSQL (see 3.3.3 on the preceding page) as database backend;
A wiki page at the developers’ website guides throughout the installa-
tion process that, unless particular configurations are needed (e.g. security
requirements), doesn’t require advanced computer science skills. Its devel-
oper team offers highly professional paid support, but the excellent user
community forum gives a great way of troubleshoot common and uncom-
mon problems for free.
After initial configuration, LabKey provides an easy and flexible system
where to upload, store, analyze and plot biological data. Studies can be
organized in nested folders, each one with specific modules enabled and
customized permissions. Case/control studies are particularly well sup-
ported by LabKey, which provides specific functions to manage data pro-
duced within this type of projects.
Moreover, additional modules are available to improve the analysis and
searchability of assays such as:
• Genotype data;
• Luminex data;
• Mass spectrometry data;
• Flow cytometry;
Finally, LabKey can also forward jobs to a Galaxy Server (Blankenberg
et al. 2010; Giardine et al. 2005; Goecks et al. 2010), transforming it in a
highly efficient genomics analysis platform.
In this thesis, LabKey was deployed on a server provided by the Univer-
sity of Bologna’s IT Department to aid NU-AGE data validation process
and act as a temporary storage for the data that, once finalized, will be
transferred to the dbnp (see 3.3.4 on the facing page).
3.4 programs and algorithms
Implement something from scratch when somebody else already did the
job is useless (and somewhat silly), and this concept holds both for pro-
gramming languages libraries and for whole softwares. The development
of this thesis took advantage from many freely available algorithms to ad-
dress some of the tasks, and hereby follows a list of them.
3.4.1 Phred, Phrap and Consed
Building a consensus sequence out of tens of chromatograms coming out of
a Sanger sequencer can be a tough work, even when the target is a small
molecule such as the mtDNA. Many different suites exist to reduce the bur-
den of this work, implemented by sequencers manufacturers or independent
developers. Our lab adopted for this task SeqscapeTM (Applied Biosystems
Inc. part of Life Technologies, Carlsbad, CA), but it lacks support for some
chromatograms formats used in the GEHA project. This forced us to move
to a different pipeline, based on Phred, Phrap (Ewing et al. 1998a,b) and
Consed (Gordon et al. 1998).
The process is rather straightforward:
1. Phred loads and analyzes the raw files coming from the sequencer,
calls the bases and computes a quality value for each of them, as a
logarithmic function of the error probability.
2. Phrap reads Phred outputs and assembles the contigs using the mito-
chondrial DNA reference sequence (Anderson et al. 1981; Andrews
et al. 1999) as a scaffold.
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3. problematic sequences can then be further manually refined with Con-
sed, a graphical user interface (GUI) to view Phrap output, if needed.
Phrap strong point is represented by the calculation of additional qual-
ity indexes that, supported by those produced by Phred, allows it to use
a higher fraction of each read, as long as the quality is high enough to be
aligned to the other reads. This helps increasing the throughput of the pro-
cess, in turn lowering the need of human intervention: there’s no more need
for an experienced operator to recover erroneously discarded fragments to
link otherwise separated contigs, an common issue with other softwares
where reads are trimmed aggressively. If needed, Consed GUI can help in
finalizing particularly tricky sequences.
In this thesis, this suite was used to reconstruct GEHA sequences starting
from raw data produced by the Beijing Genomics Institute (BGI), China.
3.4.2 ClustalW2 and Clustal Omega
A direct way to evaluate the quality of a consensus sequence, apart of the
quality values produced by the assemblers, it’s comparing it to the reference
sequence: the identification of many mismatches, far more than expected, is
usually a very bright indication that something went wrong, possibly at the
sequencing or assembling step.
However, to compare two sequences we must align them first. Aligning
together many samples, usually against the reference sequence, in a single
alignment would help the operator in assessing the quality of each of them
in a single shot, dramatically reducing the time needed to check the whole
batch. This kind of alignment is called Multiple Sequence Alignment (MSA),
and, just to avoid overlapping, there are a very long list of softwares to
do so, each one with its own advantages. After careful testing in terms of
time and alignment accuracy, we eventually found that ClustalW2 (Larkin
et al. 2007), albeit a little slower than Muscle (Edgar 2004), produced more
consistent results. When ClustalW2 was officially no longer maintained, we
switched to Clustal Omega (Sievers et al. 2011), an excellent implementa-
tion of the next generation of multiple sequence alignment algorithms.
ClustalW2 and Clustal Omega were used within this thesis to evaluate
the quality of the GEHA mtDNA sequences produced in Bologna and at the
BGI.
3.4.3 FastQC
The difficulty of evaluating the quality of sequences obtained via Sanger
sequencing simply fades away when compared to the complexity of quality
control in Next Generation Sequencing (NGS), when thousands – or hundreds
thousands – small reads are at play. Luckily, with the progressive, in some
way explosive, adoption of these technologies tools were designed to help
researcher and technicians in evaluating the quality of this flood of data.
A very good example of this is FastQC (FastQC Website), which provides
an integrated – and easy – way to perform basic quality control checks on
the raw data coming out from the NGS sequencer. The user has just to load
the file (usually a BAM file) and the program will compute common key
statistics and display them in a friendly interface. An example of a (bad)
run can be seen in Figure 5 on the next page, with quality values dropping
low just few bases after the reads start.
FastQC was used to evaluate the quality of the data produced by an Ion
Torrent platform while optimizing a protocol for complete mtDNA sequenc-
ing.
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Figure 5: FastQC screenshot. On the left we have the list of available statistics, with
semaphore-based colors depending on the statistics results themselves. On
the right a clearly bad run, with mean quality scores dropping below opti-
mal values (green shadow) early in the reads.
3.4.4 Swiss-army knifes for genomics data management
Samtools (H. Li et al. 2009b), bedtools (Quinlan et al. 2010) and Picard (Pi-
card Website) are toolkits to manage, view and analyze high-throughput se-
quencing data. Combining them you get a fully-featured Swiss-army knife
that can sort out many – if not all – the problems you may encounter in
selecting, merging, splitting, indexing and viewing data in SAM and BAM,
the most adopted formats for raw NGS data.
Detailing all the task they can perform will result in a 10 pages and count-
ing long list. Eventually, only Picard was used in this thesis, but all of them
were thoroughly tested.You will get a complete view of where we used Pi-
card in the next chapter but, for the moment, just know that we used them
in our quest of improving the variants called by an Ion Torrent platform.
3.4.5 GATK
Getting the data out of the sequencer and view them is the first step in a long
pipeline. What you’re really looking for when sequencing are the variants
each subject harbors in his or her genome. Technically speaking, you must
call the variants in that genome. Given the very high number of reads NGS
sequencers produce, the amount of information you must consider to call
a single variant may turn out to be enormous. You clearly need advanced
algorithms to condense all this information in a single nucleotide call.
The Genome Analysis ToolKit (GATK) (DePristo et al. 2011; McKenna et
al. 2010) disentangles this problem combining complex statistical modeling
with efficient implementations of the algorithms to increase the sensitivity
and specificity of the calls, while also keeping low the CPU and memory
footprint of the system. To help first-time users, the GATK development
team published and constantly updates Best Practices for different use cases,
with comprehensive examples on how to execute and master each command
the pipeline is composed of(Van der Auwera et al. 2013).
GATK HaplotypeCaller was used in this thesis to perform variant calling
on samples sequenced with the Ion Torrent Platform.
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3.4.6 HaploFind
HaploFind (Vianello et al. 2013) is a web application developed at our lab
to perform high-throughput SNP discovery and haplogroup assignment of
complete mitochondrial DNA sequences. Implemented in the context of my
master thesis, the web application is now gaining a small but significant
momentum among researchers, with a constantly growing user base.
The application allows to load a set of mtDNAs in FASTA format that
are then automatically aligned against the mitochondrial reference sequence
(RSRS, Behar et al. 2012) to detect variants. Once the mutational signature
of each samples is defined, HaploFind compares it to the Human mtDNA
Phylogenetic tree (PhyloTree, van Oven et al. 2009) to find the best match
between detected mutations and known variability. Results are then sent
back to the browser and displayed in a Javascript-based web interface for
navigation, refinement and exporting.
The whole process is usually very fast, with a lower bound of 0.09 second-
s/sequence for the snp discovery and haplogroup assignment step, which
increases to ~0.9 seconds due to the overheads caused by data insertion/re-
trieval in the database and job queue management.
HaploFind carried out the SNP discovery and mtDNA haplogroup assign-
ment on GEHA sequences.
3.4.7 EpiData Entry
Epidata Entry (EpiData Entry Website) is, citing the developers’ website, a
software for
simple or programmed data entry and data documentation.
It allows to build complex yet easy to use interfaces for the data entry in
the context of scientific projects and beyond. Validation of the data can be
coded exploiting a dedicated programming language, that allows for the
creation of advanced checks with relatively small efforts. It also has built-in
function for data export and backup.
In this thesis we adopted EpiData Entry to build the data entry interface
for the NU-AGE project.
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In the last 3 years, I’ve been involved in many different projects – some-
times just an idea of a project – a part of which made their way in the Results
of this thesis. The same premise made in Material and Methods holds strong
also here: each project had its own requisites, which were addressed with
the most appropriate computational answer. Sometimes 20 lines of script
did the job, in other cases entire pipelines were coded from scratch. I will
first start discussing the biggest challenge I personally faced, and then move
on to the other topics.
4.1 nu-age - the data challenge
NU-AGE aims to understand the role diet, in particular a fortified diet
focused on elderly’s needs, may play in longevity and healthy aging. To
achieve its objective, the project collected an unprecedented amount of data,
deeply characterizing 1250 subjects before and after a one year-long diet in-
tervention followed by half of the enrolled cohort. This fine characterization
encompassed different areas, from phenotypical data such as physical and
cognitive indexes to DXA scans and cutting-edge omics analyses.
Cracking open the inner mechanisms that diet may use to impact on lon-
gevity must go through efficiently leveraging the collected data to find the
needle in the haystack. NU-AGE, apart from the innate complexity of the
intervention itself, represented a big challenge even for data managers. Tack-
ling the data problem required to act at different levels, to ensure data were
entered and stored consistently.
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Table 3: NU-AGE questionnaires and assays schema
Questionnaire Datasets Timepoints
Admission 1 Admission 1 Time 0
Admission 2 Admission 2 Time 0
General
General Time 0 Time 0
Prescribed Medicines T0 Time 0
General Time 1 Time 1
Prescribed Medicines T1 Time 0
Interview
Interview Time 0 Time 0
Interview Time 1 Time 1
Blood & Urines
Blood & Urines Time 0 Time 0
Blood & Urines Time 1 Time 1
Energy Expenditure
Energy Expenditure Time 0 Time 0
Energy Expenditure Time 1 Time 1
Supplement
Supplement Time 0 Time 0
Supplement Time 1 Time 1
Follow-up
Follow up Month 4 Month 4
Prescribed Medicines Month 4 Month 4
Follow up Month 8 Month 8
Prescribed Medicines Month 8 Month 8
Follow up Month 12 Month 12
Prescribed Medicines Month 12 Month 12
Vitamin Da Vitamin D Months
4, 8 and
Time 1
DXA
DXA Time 0 Time 0
DXA Time 1 Time 1
Nutrients
Nutrients Time 0 (7 days average) Time 0
Nutrients Month 4 (3 days average) Month 4
Nutrients Month 8 (3 days average) Month 12
Nutrients Time 1 (7 days average) Time 1
Exit conditions Exit conditions Time 1
a Contains Month 4, Month 8 and Month 12 data together.
4.1.1 The wealth of data
In defining the pipeline that would have dealt with NU-AGE data, the first
step was to exactly define which information the project planned to collect,
down to the level of each single variable. There’s a first sharp distinction to
be made here, separating:
• Phenotypical data, obtained via questionnaires;
• Data produced by assays, such as fresh blood analyses, DXA and
omics assays.
which need to be managed in different ways.
There is also a second distinction regarding data: some are obtained by
each recruiting center independently (i.e. questionnaires, DXA, fresh blood
analyses), while others are centralized to reduce the biases different instru-
ments and labs may cause. Table 3 provides a list of the firsts, while Table 4
on the next page details the centralized assays.
Roughly speaking, the number of variables datasets comprised in the first
table will produce is ~2040. We still can’t estimate the same number for
the centralized analyses: for some of them the output cannot be exactly
determined upfront, while for others involved labs are redefining the data
formats on-the-fly to improve later usability.
After obtaining a clear picture of the data the project was collecting, we
proceeded to design a proper data management plan to address the issues we
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Table 4: NU-AGE Centralized assays
Assay Timepoints Analyzed subjects
Cytokines / Interleukines
Time 0 1250
Time 1 1250
Citomegalovirus Time 0 1250
Genetics (Illumina 750K) Time 0 1250
Microbiota – Phylogenetics
Time 0 1250
Time 1 1250
Ferritin – Soluble transferring receptor Time 0 1250
Time 1 1250
Microbiota – UCC
Time 0 120
Time 1 120
Serum – UCC – Calcium, Vitamin D
Time 0 1250
Time 1 1250
Lipids
Time 0 1250
Time 1 1250
Metabolomics – INRA
Time 0 120
Time 1 120
Microbiota sequencing – HITChip
Time 0 120
Time 1 120
Plasma – IFR – Hormones
Time 0 1250
Time 1 1250
Plasma – IFR – Cytokines
Time 0 120
Time 1 120
Metabolomics on serum
Time 0 120
Time 1 120
Metabolomics on urine
Time 0 120
Time 1 120
Metabolomics on feces
Time 0 120
Time 1 120
Transcriptomics
Time 0 120
Time 1 120
Proteasome / Immunoproteasome
Time 0 120
Time 1 120
Serum – ORU – Liver functionality
Time 0 1250
Time 1 1250
Telomere length on PBMC
Time 0 120
Time 1 120
Telomere length on whole blood
Time 0 1250
Time 1 1250
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found, making life easier for people that would come later, data analysts
on top of the others. This last consideration gently pushes us to the next
section: errors, and why we must fight them.
4.1.2 Why we must fight errors
Massive projects, if not carefully managed, usually produce massive amount
of dirty data requiring extensive cleaning afterwards, if any cleaning is fea-
sible at all at that point. We all experienced the bad feeling of a shiny new
dataset that promises wonders, only to find that some of the variables are
missing, some shows suspiciously different behaviors depending on the re-
cruiting center (SOPs problems) and, maybe, some are encoded in a un-
known way. Sum small and not-so-small problems like these in all the
datasets obtained within a project and you’ve a screwed research project
that will end in a very big and thick smoke cloud.
The reason we must fight errors from the very beginning is obvious: not
wasting efforts, time and, ultimately, money. NU-AGE is a complex project
that aims to combine together data coming from completely different areas
and must rely on a clean database to build its foundations upon. We can’t
think about advanced techniques if even a one-floor building will collapse
in no time.
This leaves us with a big, red-flashing question: how to fight errors?
4.1.3 How to fight errors
Clean datasets require good plans on how to detect and fix errors in the
data. In NU-AGE we committed ourselves to be quite aggressive against
errors, acting at many different levels:
1. Data entry was strictly done via a data entry interface developed to
validate the data on-the-fly, unless they were automatically produced
by a software or lab instrument (i.e. DXA). In this second case, datasets
were accepted without further checks.
2. Data gathered in with the data entry interface were exported and sent
to UNIBO, where an in-house developed data validation pipeline re-
validated the data from scratch, applying checks beyond the data entry
interface capabilities.
3. Continuous data not having clear expected ranges (again, DXA is a
good example here), which thus cannot be easily validated against
a set of fixed rules defined a priori, were validated visualizing their
distribution and pointing out outliers.
4. Each center data was uploaded in separate folders in the database,
and merged together only afterwards. This allows for full control on
information history (all uploads are retained in the database) while
ensuring only the latest (and hopefully most correct) version of the
data is available to authorized staff.
5. Data requiring specific skills to be validated were forwarded to part-
ners within the project with recognized experience in the field of in-
terest. Cleaned datasets were then sent back to the data management
team and uploaded in the database.
As you may have already understood, the first and only aim of this multi-
level validation pipeline was to detect errors quickly and as close as possible
to the data entry time. It’s much more easier to correct, or at least double-
check, a value when source documents are still around, than if the same
request comes in 3 whole years after the subject inclusion, with all the "pa-
perwork" locked somewhere else.
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4.1.4 Striving to document
Suppose in 5 years from now – after the project end – someone asks for
the heart beat, or handgrip, values in the cohort. Which was the variable
encoding the value? And, why subject 789 has a so low value? Was him
bradycardic or something went wrong in the measurement? Should a data
analyst throw away the subject as an outlier, or there’s a reason behind the
value and he should keep him? What about subject 566, which has the same
problem? That’s exactly the reason why documentation in scientific projects
is a must have: data are valuable, and people should be able to use them in
the future without getting mad asking themselves if a value valid or not.
NU-AGE obviously faced this issue: with 1250 enrolled subjects, it was
only a matter of time before some strange - but valid - value made its way
into the database. We thus decided to plan ahead: we gave recruiting cen-
ters an easy way to flag false positives they may encounter, provided they
had a meaningful reason form them, while on our side these reasons were
stored to track why failed checks were silenced. In this way, when the data
entry process will be completed, we will be able to provide to data ana-
lysts an handbook detailing each exception along with its reason. At the
same time, we’re are assembling documentation about the variables, detail-
ing from where each variables comes from, the logical block in which it was
originally comprised, and, if applicable, question text, expected ranges and
dictionaries used to encode the answers.
All together, these files will constitute a sort of "NU-AGE data manual"
that will hopefully answer most of the questions researchers will have when
playing with the data for the first time.
4.2 nu-age - validating the data
What we just saw is the theory of data management. However, going from
theory to practice needs a lot of efforts to translate these rules in softwares
and, possibly, documentation. What will follow is an accurate description
of how we implemented this theory in the NU-AGE project.
4.2.1 Data entry interface
Checks at data entry level are the first line of defense against errors in the
datasets. It’s probably the most effective measure: if the medical doctor or
the researcher enters a value outside what was expected there’s some sort of
notification that immediately warns him about the issue and the information
can be verified on the source documents in a matter of seconds. However,
there’s an intrinsic limitation in this approach: the systems behaves well
only when there are clear sharp bounds that depends only on data already
entered into the system. We can safely throw out an alert if someone tries
to enter information about an abortion for a male (given we already know
the subject is a male), but saying if that hearth beat is outside what it is
normally expected, well, that may be a little bit trickier.
Anyhow, building a data entry interface requires a suite to base it upon,
which should ideally have two key features:
• Easy to code Case Report Forms (CRFs, sometimes also referred to as
eCRFs, where e stands for electronic);
• Easy to fill forms;
When we evaluated how to implement the CRFs for NU-AGE we had to
consider the following points:
• No server was available to host a dedicated web application (i.e. Open-
Clinica, OpenClinica LLC and collaborators, Waltham, MA, USA, www.
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OpenClinica.com.) and acquiring a new one was off the table for sev-
eral reason;
• Time was an important factor, since recruiting was about to start and
data entry should have started soon thereafter;
• We didn’t have a solid background in this field, thus an easy to learn
system was mandatory;
• Due to the short time to deploy, we had for sure to fix bugs after
deployment, and we needed a plan for that;
• Ideally, concurrent usage by multiple users could have been useful,
but it’s very difficult to obtain it without a client-server architecture in
place;
• Different centers had different needs, so flexibility in development and
deployment was a must (this later forced us to maintain 3 different
platforms).
After carefully evaluating the candidates, and with all the server-based
excluded a priori due to server unavailability, we choose EpiData Entry (Ep-
iData Entry Website) to develop our interface. This software had several
advantages:
• Coding questions and validation checks was straightforward, being
the whole system based on a trivial language and text files;
• Deployment could be done manually by each user, or automatically
by a setup program;
• Each center had it’s own interface, so different needs could be ad-
dressed separately;
• Data were stored locally and then exported to the database. In this
way, recruiting centers had immediate access to their own data, as per
project agreements;
• Bugs could have been solved on a test interface in Bologna, and patches
deployed via remote connection powered by TeamViewer (TeamViewer
GmbH, Göppingen, Germany, http://www.teamviewer.com/)
• Being the interfaces physically separated, any technical problem occur-
ring in one of them, i.e. not foreseen edge cases, would have affected
only the data collected in that given center;
The only problem still open was to allow for the concurrent usage of the
platform by different users at the same time. However, concurrency is quite
a complex feature to obtain without relying on a client-server architecture.
Indeed, EpiData Entry does not support this natively: once files are opened
by a process (a user) they are locked for opening by others. However, af-
ter some discussion with the partners, we realized that the feature we were
missing was indeed the possibility to access the system from different com-
puters, and not concurrent access. In this case a workaround do exists: both
the software and the configuration files were moved to a network share
where authorized users had write access to and, since the program doesn’t
need to be installed to work, it was possible to launch the interface directly
from within the share. This setup also has a side-advantage: most of the
network shares provided by universities undergo backups on a regular ba-
sis, and moving the interface on those systems ensures that all the entered
data are backupped automatically without additional effort.
So, granted that EpiData was probably the most adequate answer to our
needs in that particular moment, we still had to code the CRFs. When we
started developing the interface, back in 2012, there were two different im-
plementations of EpiData available: an older, stable version with a lot of
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field testing and a new, completely rewritten version that was in its early
stage of development (usually referred to as alpha and beta). The newly
developed platform was really promising: it solved most of the chronic
problems the previous suite suffered from and made CRFs creation even
easier. However, the codebase was so unstable at that point that the devel-
opers themselves discouraged the adoption in production use. Additionally,
some features required to fully implement the NU-AGE interface were still
missing. We were thus forced to adopt Epidata Entry v3.1, the last version
available of the older Epidata implementation.
Implementing eCRFs
Implementing a basic CRFs in Epidata is relatively easy, provided that the
developer has some programming rudiments. A data entry form is made
of two files: .qes and .chk, where the first defines the questions and links
them to the proper variable name and format and the second defines the
validation checks to be used.
An example of how we declared the fields storing subject code, name of
interviewer and date of administration in Admission 1 questionnaire (.qes
file) is the following:
1 code Subject Code ######
2 interadm1 Interviewer
↪→ ____________________
3 interadm1d Date of interview <dd/mm/
↪→ yyyy >
There’s already some information in these lines: each variable is declared
(first string, i.e. code) and linked to the corresponding question and the
proper field type and length is defined, where:
• "#" stands for a figure, so 6 "#" symbols in a row mean an integer
value of maximum length 6. Adding a dot, such as "#.#", codes for
float values, in this case with a single decimal digit;
• "_" stands for a character, and the number of "_" is directly propor-
tional to the maximum string length;
• <dd/mm/yyyy> codes for a date.
If no additional validation rules are needed in this form, the CRF is ready
to be used. However, that’s not the way things usually go: there are ad-
ditional checks we need to apply to our data to detect wrong values. In
EpiData these checks can be declared in the check file (.chk), and the checks
counterpart for the questionnaire above is the following:
1 code
2 NOENTER
3 KEY UNIQUE
4 TYPE STATUSBAR "IDCODE = "
5 END
6
7 interadm1
8 MUSTENTER
9 END
10
11 interadm1d
12 MUSTENTER
13 AFTER ENTRY
14 IF interadm1d > Today then
15 HELP "Dates in the future are not allowed" TYPE
↪→ =ERROR
16 GOTO interadm1d
17 EXIT
18 ENDIF
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19 END
20 END
There are three main blocks in this piece of code: each one starts with
one of the variables we saw in the previous snippet, ends with a capitalized
"END" and defines the validation checks for the variable whose name opens
the block. Indentation should help in identifying them.
Skip the variable "code" for now – it has a special meaning – and focus
on "Interadm1", which stores the name of the interviewer. This may be a
valuable information in case discrepancies due to different ways of admin-
istering the questionnaires among the recruiters arise later on. Anyhow,
there’s really nothing we can validate here, apart of the fact that this field
can’t be blank, and that’s exactly the job the "MUSTENTER" command does:
it throws an error if the field is left empty. For "interadm1d", which holds
the date of the questionnaire, we can instead do something more: again, this
field can’t be blank, but we can also make sure that the date is not in the
future. Data entry is done after a questionnaire is filled (in the ideal situa-
tion on the same day), but never before. Thus, a date in the future doesn’t
make any sense in this context. EpiData gives us the bricks to build this
check: the "AFTER ENTRY" block, which is invoked every time the field
goes out of focus, i.e. the person moved to the following field, and the spe-
cial variable "Today", which always contains the current date. To implement
our check we compare "interadm1d", which stores the date the person just
entered, to the current date to verify if it is greater (to be read: it is after).
If the comparison is true, we throw out an help box of type "ERROR" with
text "Dates in the future are not allowed" and, when the box is closed, we
move the focus back on the "interadm1d" field with the GOTO instruction,
so the error can be fixed. The EXIT command grants that, if an invalid value
occurs, no further processing is done, preventing further errors to happen.
Finally, the ENDIF instruction terminates the IF block.
We now go a step further analyzing the variable "code", which allows us
to introduce a new concept: relational eCRFs.
Relational eCRFs
PostgreSQL, the DBMS we saw in section 3.3.3, can also be defined as a
RDBMS, where R stands for relational. Briefly, relational databases are sys-
tems in which tables storing different type of information are linked to-
gether by mean of an unique key that is present in all the tables. Keys are
the glue that keeps the whole database together. With EpiData you can
do more or less the same: subdivide information within different question-
naires, and glue everything using a key. In our implementation, the variable
"code" represents the key. Going back to the previous code snippet, you can
see that the first command for that variable is "NOENTER", which prevents
the user entering the field, since the code is automatically filled by EpiData
and we don’t want the user to fiddle with it. The next instruction is then
"KEY UNIQUE", which means "this variable is a unique key, so the string
entered here must be unique among all the records", exactly as a patient ID
should behave. The last code line customizes the interface, displaying the
current PID the user is working on in the bar at the bottom.
For NU-AGE, we exploited this relational architecture and built a bogus
form that was used as a entry point to access all questionnaires. There are
only two fields in this fake form: the PID the user is going to enter the
data of and a integer field ranging from 1 to 17, which corresponds to a
progressive id assigned to each questionnaire. Each CRF was implemented
separately and hooked back to the main page via Epidata command "RE-
LATE". Once the user enters the PID of the subject and the questionnaire id
he or she wants to enter, the program automatically loads the CRF and, if a
record with that PID already exists, displays the stored data. Otherwise, a
new blank record ready to be filled is created.
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The advantages this approach guarantees are obvious:
• Every questionnaire is separated from the others and must be accessed
on purpose to modify the data;
• Only the selected CRF pertaining to the selected subject is editable. All
other records are locked, decreasing the risk of data entry errors;
• Every questionnaire constitutes a separate dataset, that can be ex-
ported and managed independently. When you’re dealing with 2000+
variables, this is an important plus.
Exporting data
After being entered in the interface, data must be exported in a format com-
patible with the rest of the data management pipeline. Since this step is
carried out by the user, the process should be as user friendly as possible:
lower complexity directly relates with fewer errors. Unfortunately, EpiData
Entry does not provide any way of exporting all the CRFs linked to our
main interface as a whole. Instead, the user would have to open each ques-
tionnaire one by one, export the data and then close it. It’s not a only matter
of repetitiveness: the critical point is that in this timeframe the questionnaire
would be open for modifications, without the safe boundaries given by the
relational architecture described above.
Luckily, the EpiData Association, the associations that steers the present
and the future of EpiData, developed the EpiData Command Application
(EpiC). This utility, that can only be invoked from a DOS command prompt,
can export the data contained in an EpiData Questionnaire without external
assistance in many different formats. In our case, we chose a text-based
TAB-delimited format (see 3.3.1). Nonetheless, EpiC can do the job, but
still one questionnaire at the time. EpiData Entry toolbox, however, wasn’t
empty yet: the "EXECUTE" command permits to invoke external programs
from within a CRF. We thus coded a .bat file, a list of DOS commands that
are executed one after the other once the file itself is executed, that did two
jobs:
1. Delete any previous export for the given questionnaire;
2. Export the data for the questionnaire.
The file was then connected to the main page thanks to the "EXECUTE"
instruction: when a user enters 17 as questionnaire id, no CRF is opened
but the export procedure is triggered and exports build automatically in a
previously configured folder.
Complexity is bad - how to configure everything easily?
Complexity, at least on the user side, is bad for a thousand reasons, some
of which we detailed above. Once properly deployed and configured, the
interface was very easy to use, even by people without specific training. Yet,
properly configure the system remained a complex task, especially when
dealing with the settings needed to configure the paths were the interface
was supposed to export the data and store backups. Trusting in the user for
these tasks was off the table, and we thus decided to implement an installer
based on the excellent Nullsoft Scriptable Install System (NSIS), a profes-
sional open source software used to create Windows installers. The result
was a easy-to-use installer that took care of asking users where exports, back-
ups and the interfaces itself were to be installed and of customizing center-
dependent checks (i.e. first digit of the NU-AGE PID is center-dependent,
and we had a check on that). We also wrote a manual covering all the daily
operations users may had to do, which also doubled as a first-aid help in
case of minor issues.
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All the initial interface deployments were powered by this automatic in-
staller, but it was soon clear to us that that wasn’t a "shoot and forget"
problem. Most of the centers needed further assistance, so we adopted
TeamViewer to fix issues and deploy updates remotely.
We briefly mentioned backups: EpiData do implements a backup routine,
and we instructed it to do so each time it was closed, aggregating the data at
day level. It this way, if needed, we were able to track the data entry process
down to day-by-day changes.
4.2.2 The need of a new solution
Epidata was probably the wisest solution to address NU-AGE needs given
the strict requirements we had, but was not downsides-free.
The first and biggest was (and is) the lack of central control once the in-
terface is deployed. We’re getting back again at the problem of having a
server to manage the study and to the fact that, if proper resources are avail-
able, that approach represents the golden standard that should be followed.
Monitoring the data entry process as it goes by, immediately spotting errors
in the data, being them systematic or not, and pushing out fixes in a single
place instead of chasing countless partners to schedule a TeamViewer con-
nection are just some of the advantages a central management point offers.
Adopting Epidata Entry, we faced serious problems in building advanced
checks due to the intrinsic limitations of the language it is based upon. In
some cases, we were forced to omit a check because it was too complex to
implement, or required writing a dedicated C library. Also easier checks
may stumble on the very same limitations: you can’t use data in question-
naire1 to validate a value in questionnaire2, since cross-questionnaire access
is not supported. If you have a sex-dependent test in questionnaire2 and
the sex of the subject is in questionnaire1? You can’t alter the questionnaires
structure obviously, so you must either rely on the data entered by the user,
or ask him or her to fill the gender twice in both questionnaires. Please
note: double entry is not a bad thing per se, but double entry to overcome
problems like these is pure evil.
Another important requisite to keep in mind is the possibility to track
the data failing the validation. Having values out of normal ranges is com-
mon, a light cold can alter people’s blood values out of what is normally
expected. We knew that recoding these discrepancies, together with the rea-
sons for them, would later become of striking importance. Epidata, I would
say rightly given the different scope the software has, doesn’t support that.
You can add subject-wide notes to each CRF, but without any structured
information.
Finally, the biggest limitation we struggled against: checks in EpiData can
be silenced simply using the mouse. Move along fields with the mouse, and
no check will be executed. This was the result of a precise, and sensible,
design decision: if you end up with a badly written check that blocks the
rest of the form you can recover from the situation moving out of the trou-
blesome field with the mouse. However, this had a sense when no updates
or patches were possible, but in 2015 we have emails and remote connec-
tions, so this is much more a damage than a gain. Until you have a working
internet access, of course.
From these considerations we started wondering if implementing a cus-
tom solutions was worth the costs in time and resources, and we eventually
concluded that the answer was affirmative.
4.2.3 NU-AGE Validator - a quick introduction
NU-AGE Validator was the answer to all the problems we faced using Epi-
Data as our data entry interface. Entirely built in Python, the software can
parse the .qes and .chk files we wrote to define EpiData questionnaires and
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use them as a source to rebuild its own representation of the CRFs. Once
the structure is built, the systems loads the datasets and validates all sub-
jects one by one. Each questionnaire, in Validator, can contain one or more
questions and harbor questionnaire-wide checks. In turn, each question can
define one or more checks, made from pre-defined or custom Rules.
Each check (hence, each Rule) produces a Validation Result (VR) indepen-
dently if the check was successful or not. VRs are stored in a local database
to be later used to provide a feedback on which checks didn’t pass and why,
in forms of two almost identical reports, based on the PDF and Excel format
respectively. The PDF report is made by tables detailing the errors occurred
in each questionnaire and, once printed, helps in skimming through the
source documents searching for the original information. The Excel report,
on the contrary, supports a more structured access and fulfills an additional,
very important, role by mean of two additional columns: Authorize and
Reason. These columns are part of the authorization mechanism that allows
recruiting centers to flag false positives as such and represents an important
piece at the basis of the handbook of NU-AGE data we will build once data
cleaning will be completed.
The functioning of our authorization system is pretty easy from the users
perspective: they need to respectively fill the two aforementioned columns
with the string "Yes" and with the reason why they what to authorize the
exception for each VRs they request the silencing. Validator then loads back
these authorization requests and, provided that the reason is long enough,
10 chars or more, silences the corresponding VRs.
4.2.4 NU-AGE Validator - The implementation
NU-AGE Validator can be subdivided in several different libraries, each of
them answering to a precise need of the pipeline:
• Parsers, which hosts parsers to read questionnaires and checks from
configuration files;
• Models, which hosts the definition of all the objects needed for model-
ing questions and questionnaires;
• Rules, which hosts all the rules that can be used to build checks;
• Wrappers, which host wrappers around famous Python libraries, i.e.
ReportLab to build PDFs, to make them more easy to use for our task;
• Validator, which is the script that glues everything together and carries
out the work;
There’s a pretty decent amount of code here: we’re talking of ~10000
lines written in about 2 years of development, as visible in Figure 6 on the
following page. For libraries that, for their complexity or pivotal role have
a critical importance in the pipeline we developed specific unittests, which
are automatic tests to verify that the code behaves as expected. This is part
of the "best practices" in code development, since it allows to quickly verify
if the latest changes a developer did on the code broke it somewhere else. A
best practice is also to track these changes, to immediately rollback the nasty
ones. In our case, we adopted git (Git Website), a distributed revision control
system, to fulfill this requirement. After the git repository is initialized, code
changes can be committed to it, thus obtaining a clear history of when the
codebase was changed, how, and by who. Being honest, Git can help in
all the situations in which text files are continuously modified and changes
must be tracked. An example? This thesis, which was written in Latex
(http://www.latex-project.org/), was tracked in a git repository!
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Figure 6: Validator repository size in line of codes in time. The development started
in early 2013, and ended in November 2104. Small revisions to fix bugs or
add functionalities are still developed and pushed out.
Models
The first step to comprehend Validator is to understand how the objects
modeling questionnaires and rule were implemented. Let’s start with the
smallest unit we have in our construction set: questions.
questions A question is the smallest brick we have in a questionnaire set.
A question can belong to a structured test battery, or just be self-standing.
Nonetheless, this is the level at which the information is linked to a variable
and to its own space in the database. We can isolate a common structure
among all questions, which we can resume as:
• A question text or, to use a computer science term, the representation
of the question text in the form of a string;
• A variable, which represents where the data will be saved;
• A flag that marks the answer as mandatory;
• A progressive ID, which is the progressive number of the question
within a questionnaire.
All these properties, taken together, can be seen as the core of an object
modeling a question. Obviously, that’s not the whole thing, but these are
the attributes each question must have at minimum. How many types of
questions do exists? From our point of view, we have 3 of them:
• Numeric question, which expects an answer in form of a number (in-
teger or float);
• String question, which expects an answer in form of a string;
• Date question, which expects an answer in form of a date.
So we have three different theoretical models, each one acting differently
in some cases, but which still have common attributes. Rephrasing the con-
cept, we have a model inside a model, or, even better, a "parent" model from
which the three inherit from. Python, as most object-oriented programming
languages, allows for objects that inherit from other objects. To be more spe-
cific, allows for classes – that are custom data types defined by a developer –
to inherits from other classes. Object, in Object Oriented Programming (OOP),
are instance of a class, i.e a variable containing a string is a object of the
Python built-in string class. The approach we followed was to implement a
generic Question class owning the common attributes and then define three
different classes (the three question types), which inherits from the parent
class the common core.
Why three different objects to modeling a single object, a question? The
reason behind that is that, depending on the expected answer, the object
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should act differently. The maximum allowed length for the answer is a
good example of this need: if we’re dealing with a string, it’s just the num-
ber of characters in it, but if it is instead a float number, it can be to the
length of the whole number or the number of figures before the decimal
point. Also, if we expect a string, we should throw out a warning if other
data types come in. Particular care must be used when dealing with dates,
since there are many ways of representing them (i.e. 12/02/2014, 12022014,
12/02/14 – same date, different representation) and in some edge cases it
can be difficult to distinguish between correctly formatted dates and, for
example, numbers.
Some validation checks are part of the question definition itself: manda-
tory/non mandatory flag, maximum length and wrong data type detection
are good examples of these "by definition" checks. Each check returns a
result (a VR object), which is not only a True or False flag, but also contains
additional information regarding where and why validation failed. These
objects must be collected within the question an then transferred un in the
chain to be further processed. Thus, each question possess an attribute,
check_results, which is nothing more than a list (one of Python built-in data
types) of VRs. It’s companion, the attribute checks, holds the checks to be
applied.
Questions also have methods, which are functions that help them do their
work. The most important one is (fairly obviously) "validate", which triggers
the execution of all the checks contained in a question. Other helper meth-
ods were coded, such as those used to add rules to a question or reset the
object to validate the next subject, but they will not be described here due
to space constraints. We will instead discuss two "special" methods that are
used to deal with specific events in the questionnaire logic: jumps and miss-
ing codes. The first happens when a specific answer to a question causes
the interviewer to skip one or more succeeding questions. Coping with this
requires a tight interconnection between questions, the place where these de-
viations from the expected path may occur, and questionnaires, which in our
implementation are the locations where the validation progress is monitored
and, if needed, altered. Missing codes, on the contrary, are questionnaire-
wide codes used when the interviewed subject is unable to give an answer
or refuses to do so and the recruiter needs to report this condition. This
event is managed checking the entered value against a list of legal missing
codes stored in the Questionnaire object.
labels Numerical answers can be the result of numerically-coded ques-
tions, in which a list of options has a unique number assigned to each of the
items. They’re fairly common in the questionnaire world, primarily because
they help to reduce data entry errors: it’s much more easier to enter a single
number than copy a whole phrase.
As EpiData, also Validator supports Labels, a named list of numerically-
coded items a user must select from. In theory, since the numerical key is
made of progressive numbers without any missing, a possible solution to
this problem could be to define a range check with as boundaries the first
and last number of the list. However, this provides poor support in case the
validation fails: which was the item linked to the failing number? Which
were the options available?
Sticking to the EpiData implementation of Labels, we implemented a class
as much as possible similar to the definition EpiData gives of Labels. Let’s
look at the code:
1 class Label(object):
2 """
3 Class defining a Label class.
4
5 Label class is used to validate questions that have
↪→ numerically -coded answers.
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6
7 """
8
9 def __init__(self , name , labels_dict):
10 """
11 __init__ function to instantiate a Label object
12
13 labels_dict should be like:
14 labels_dict = {
15 1 : ’label 1’,
16 2 : ’label 2’,
17 3 : ’label 3’
18 }
19
20 :param name: label name
21 :type name: unicode
22 :param labels_dict: dictionary with keys and
↪→ corresponding labels
23 :type labels_dict: dict
24
25 """
26 self.name = name
27 self.labels_dict = labels_dict
In Line 1 we define the class with name "Label" that inherits from the
class "object", which is the base class all programmer-defined classes should
inherit from unless they are subclasses of other classes. We then have some
greyed-out lines: these are documentation lines that are used to explain to
people reading the code what that chuck of the program is doing. Docu-
mentation is extremely important, since the developer itself may not recall
what that class, or method, was meant for at the beginning. Further fol-
lowing the code, line 9 says "def __init__(self, name, labels_dict)". We are
defining a method here, in this case the special method "__init__", which is
called when a new object must be instantiated. This method requires some
arguments passed to it, namely:
• self, an argument all methods within a class require, represent the
object itself;
• name, the name we would like to assign to the label;
• labels_dict, a dictionary in the form key : value where the key is the
progressive number and the value the string of the corresponding op-
tion.
Once the "__init__" method is called, it carries out two operations: assign
the content of the variable "name" to the class attribute self.name and the
content of "labels_dict" to self.labels_dict. This piece of code is why the "self"
argument is needed when invoking the function: it must be possible to set
(or read from) class attributes, that are part of the class it-"self".
Obviously, there are other methods defined in this class, but we’re not
discussing them here for space reasons. For the sake of understanding how
the object works, just know that they are used to verify if a given number
is comprised within the label and to properly format the label object when
printed.
questionnaire We now go one level up in our modeling, to the Ques-
tionnaire, which is in turn composed by one or more questions and some
additional information. The attributes this class defines are many:
1 self.name = name
2 self.valid = False
3 self.pid = pid
4 self.qid = qid
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5 self.record = record
6 self.questions = {}
7 self.checks = []
8 self.check_results = []
9 self.labels = {}
10 self.jump_to = None
11 self.validate_jump = False
12 self.ref_set = None
You may recognize some old friends in here, namely checks and checks_results,
but there are also new entries. Name holds the string with the questionnaire
name, valid is a boolean flag that states if the questionnaire is valid or not, pid
is the famous Patient ID, qid a progressive id of the questionnaire within a
questionnaire set, questions a dictionary (we just saw them) that contains all
the questions, labels contains the Label classes available in the questionnaire,
while jump_to and validate_jump are need to deal with jumps management
and, last but not least, ref_set, which points to the questionnaire set (more
on that in a moment) the questionnaire belongs to.
We skipped an attribute, record, because it deserves an additional explana-
tion. Usually, each subject will go through a single questionnaire per type.
However, there are cases in which this condition does not hold, for example
when filling the list of prescribed medicines: we have multiple records for
a single subject, all with identical IDs, but we still need to track to which
entry we are referring to. Here is were the record attribute kicks in, keeping
track of the progressive id each entry has within each subject record.
Questionnaire class, as all the other classes we have seen until now, de-
fines many helper methods, that we will not list here for sake of brevity.
They encompass multiple functions, ranging from enabling and disabling
questions to adding and removing rules and labels. Finally, there’s the vali-
date methods, which in this case deserves a few more words: questionnaire
can hold checks that, due to their nature, are impossible to assign to a single
question, and that is the reason why also this class has the checks attribute.
questionnaire set Last but not least, we have the class Questionnaire-
Set. The reason for this class to exists is to group together questionnaires
that are meant to be validated together, provide some functions to properly
manage or update the set and have a single point from which validation can
be started. QuestionnaireSet allows, as Questionnaires and Questions do, to
define QuestionaireSet checks.
Rules
Validating data can be a tough work, with many different checks to be
done, each one depending on different rules. NU-AGE, with its 22 ques-
tionnaires (counting the same questionnaire administered at different times
twice), needs a fairly high number of rules to cover all the required checks.
Some of these rules follow a reusable logic (i.e. bigger than, in range), while
others cannot be easily transferred to other cases (i.e. PASE score calcula-
tion). Developing Validator, we decided to separate reusable rules, which
are hosted in the codebase, from case-specific rules that are kept in an aux-
iliary file, the content of which is loaded at runtime. This is pretty much
a semantic distinction, the inner working of both is very similar, but helps
keeping the repository clean of unneeded code.
Validator defines 16 core rules, which are reported in Table 5 on the next
page. As for Questions, also rules are divided in 3 sub-types: Numerical,
String and Dates, plus an additional type called "Conditional", which is used
to deal with rules that must check several conditions8 at once.
validation result The same library also defines the VR (Validation Re-
sult) class, which is returned by all Rules to describe the outcomes of the
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Table 5: NU-AGE Validator Rules
Rule Type Rule Name Checks if...
Numerical
GreaterThan the entered value is greater than
the base value.
SmallerThan the entered value is smaller than
the base value.
EqualTo the entered value is equal to the
base value.
InRange the entered value is between the
defined range.
String
StringEqual the entered string is equal to the
base string.
StringDifferent the entered string is different from
the base string.
StringShorter the entered string is shorter than
the base string.
StringLonger the entered string is longer that
the base string.
StringLengthEqualTo the length of the entered string is
equal to the base value.
StringLengthBetween the length of the entered string is
between the provided bounds.
Dates
Before the entered date is before the base
date.
After the entered date is after the base
date.
SameDate the entered date is identical to the
base date.
BetweenDatesRange the entered date is comprised
within the provided dates.
Conditional
Conditional a list of conditions in a question-
naire are true. If yes, the question-
naire is invalid.
ConditionalEmpty a list of condition in a question-
naire is true and a specific field is
empty. If yes, the questionnaire is
invalid.
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validation process. Each VR needs some mandatory information to be cre-
ated, which can be provided in form of the Rule Object originating the VR
from which the init method will autonomously extract the needed data, or
as single arguments. Required parameters are:
• pid, the subject pid;
• qid, the numerical code of the questionnaire where the VR was pro-
duced;
• record, the record where the VR was produced;
• variable, the variable producing the VR;
• prog_id, the progressive id of the question producing the VR;
• help_text, an help text to provide to the user to help him fixing the
error;
• rule_id, an unique id composed by a combination of the Rule name
and defined constraints.
If, and only if, the VR reports a failure it is also mandatory to provide the
failing value. Taken together, all the attributes stored in a VR do represent
an unique firm that clearly defines which rule is failing in which subject: in
other words, a unique key.
external rules Some of the rules we defined to validate NU-AGE data
were too specific to be included in Validator core and are kept in a separate
library, loaded at runtime. In this way, Validator codebase remains slim,
while developers can add all custom checks they need. In NU-AGE, a total
of 27 external rules were defined.
An External Rule must fulfill all these condition to be considered valid:
• Inherit from Rules class;
• Possess the methods:
– __init__;
– validate;
– build_id, to build the unique Rule ID used in the VR creation.
• Always return a VR as the final result of the validation process.
Defining an external rule is just half of the job: developers must also tell
the system where these rules must be applied to have a working check. To
streamline this process Rules library contains the ExternalRule class, which
has two methods: one for initializing the class (the "__init__" we already
saw) and one for loading the rules into the appropriate questions.
The initialization function accepts two arguments: a list of destination
questionnaires with the variable where checks should be loaded into, and
the Rule object of the custom rule. On the contrary, the loading function
accepts only a single argument: the QuestionnaireSet containing the desti-
nation questionnaires. This second function iterates over the provided desti-
nations, loads the questionnaires from the QuestionnaireSet and injects the
Rules in their destination questions.
For example, the following piece of code
1 ExternalRule(destinations_list =[
2 ([’NU-AGE Interview Questionnaire - Time 0’,
3 ’NU-AGE Interview Questionnaire - Time 1’],
4 ’antbmi ’)],
5 rule_object=BMI(variable=’antbmi ’)
6 ),
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loads the Rule BMI (computes the BMI starting from height and weight)
in the variable "antbmi" inside the questionnaires "NU-AGE Interview Ques-
tionnaire - Time 0" and "NU-AGE Interview Questionnaire - Time 1".
Loading checks in this way can be helpful in a second case: suppose
you’ve a set of questionnaires in EpiData and you load them in Validator
thanks to the parsers library. However, the CRF designer left out a check
you now want to add and the corresponding rule is already comprised in
Validator core. This need can be easily fulfilled by defining an ExternalRule,
as described in this example:
1 ExternalRule(destinations_list =[
2 ([’NU-AGE Interview Questionnaire - Time 0’,
3 ’NU-AGE Interview Questionnaire - Time 1’],
4 ’sys1’)],
5 rule_object=InRange (90, 200, help_text="Systolic value
↪→ should be within 90 and 200", variable=’sys1’)
6 ),
Here we have an InRange rule, which is coded in Rules library, which will
be added to the variable sys1 (systolic pressure) on top of the configuration
originally defined in the CRF. This is a real world example: in NU-AGE
we intentionally avoided checks on blood pressure values after receiving
suggestion in not doing so by recruiting centers. However, when we realized
that in this way we offered an easy game for absurd values to reach the
database, we added a range check in Validator, without losing time in going
back to each EpiData interface.
Parsers
We have now understood the basics of how a Questionnaire is modeled in
Validator, how checks can be defined starting from Rules and even how to
add specialized Rules that are not comprised in Validator core. We still,
however, need to load the configuration defining questionnaires, rules and
so on.
Validator has an automatic way to accomplish this task using parsers.
Parsers are pieces of code that read a format and returns back native, in this
case Python, objects. NU-AGE data entry interface was made with EpiData
Entry, so we designed a parser to interpret that format and create Validator
objects staring from EpiData files.
Later down the project we realized that it would have been helpful to val-
idate also datasets not coming from questionnaires, i.e. DXA assays results.
One possible solution was to configure a fictitious questionnaire in EpiData
format, but spending time in writing a now abandoned format (EpiData En-
try is no more supported, in favor of the new version of EpiData) seemed
us awkward. We thus decided to draw from the long list of serialization
formats to choose the one that better matched our needs, and we eventually
adopted YAML (YAML Website), a human-friendly data serialization stan-
dard for which Python has a nice library to interact with. On top of this
library we built our parser, which allows to quickly and easily define new
datasets to be validated, along with the needed checks, in a single YAML
file.
epidataparser Questions and checks are contained in two separate files
in the EpiData format: it is thus mandatory to parse both to fully reconstruct
the questionnaire structure. However, correctly understand the schema of a
.qes file can be really complicated, since it also defines questions formatting.
EpiData Entry can build, combining the .qes and .chk files together, a .not
file, which includes most of the information we had in the two initial files
within a single source. Here’s a snippet of it:
1 Fields in data file:
2
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3 No. Name Variable label Field type Width Checks
4 -----------------------------------------------------------
5 1 code Subject Code Number 6 Key unique 1
6 NoEnter
7
8 2 interblur Interviewer Text 20 Must enter
9
10 3 interblurd Date of Date 10 Must enter
11 interview More: See check
12 file
It’s rather easy: a table detailing most of the information we need to build
our Questionnaires. However, this format has several shortcomings:
1. Columns are separated with spaces, not tabs. To be precise, each col-
umn is separated from the next one by a different number of spaces,
which makes parsing the file extremely complex;
2. If the text of the question ("Variable label" in the example above) is too
long, it gets truncated. So, to have the full question text we must in
any case parse the .qes file.
3. Not all the checks are reported here. The "More: See check file" string
in the example says exactly that: there are custom checks for that
variable, and you should read the .chk file as well.
The .not file is certainly of help, but does not resolve the situation.
So, resuming: we need to parse three different files, but most of them
doesn’t have a clearly defined structure. Given the requirements, regular
expression was the answer to our problem. In computer science, regular
expressions are sequences of characters defining a search pattern, i.e. we
may look for something like "A number of three figures, followed by one
or more tabs and by a word of length 3". We adopted this approach to
parse the three files: regexp, helped by Python functions for more basics
and predictable tasks, extract the information, which is then processed to
determine which question or rule type to use depending on the situation,
ultimately reconstructing each Questionnaire. All questionnaires are then
grouped together in a QuestionnaireSet for manipulation.
yamlparser YAML (or YAML Ain’t Markup Language) is a data serializa-
tion format that focus on human friendliness. It is easy to read and write
for humans and provides a fully fledged environment where to define a
Questionnaire object along with its validation checks.
To prove you this claim, here’s a piece of code defining the first two vari-
ables in our DXA dataset:
1 ## DXA T0 dataset
2 questionnaire: NU-AGE DXA T0
3 missing_codes: [-9]
4 questions:
5 - variable: code
6 text: code
7 field_type: int
8 max_width: 6
9 mandatory: True
10 - variable: Android/gynoid fat mass
11 text: Android/gynoid fat mass
12 field_type: float
13 max_width: 20
14 mandatory: True
15 checks:
16 - type: InRange
17 lower_bound: 0.27
18 higher_bound: 1.11
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19 help_text: Android/gynoid fat mass should be
↪→ between 0.27 and 1.11
This is a clear example of a programming language that does its best to
behave as nearly as possible like human language. The structure is straight-
forward: attributes are defined one per line with a "attribute : value" schema,
whereas lists are defined simply indenting the items and prepending them
with a "-".
Python has a library that automatically parses the YAML format and gives
back its content in ready-to-use Python data types, making the whole she-
bang of reconstructing YAML-based questionnaires much more easier. For
comparison, EpiDataParser is made of 824 lines of code, YamlParser of only
229. All the difference is made by the need of parsing from scratch the for-
mat in the first, while in the second we just need to instantiate the correct
objects starting from the data already parsed by Python yaml library.
If YAML files are detected, Validator automatically parses them and adds
the questionnaires to the QuestionnaireSet generated by EpiDataParser, or
creates a new one if it doesn’t exists already.
Wrappers
Wrappers in computer science are thin layers of code that translates an ex-
isting library interface into a more "compatible" interface for the problem
you’re addressing. Usually, these layers are created to lower the burden of
complex libraries with thousands of option for novice users or for users that
don’t need such a level of customization.
There are three wrappers in Validator:
• DBWrapper, to interact with databases, built on top of SQLAlchemy;
• PDFWrapper, to create PDFs, built on top of ReportLab;
• ExcelWrapper, to create Excel files, built on top of openpyxl;
The role of each of them is to decline the library their are based upon in a
way that nicely interacts with Validator classes and objects, making building
a PDF or Excel report a matter of a couple of lines of code.
dbwrapper Probably the most important wrapper among the three, Db-
Wrapper allows Validator to talk with a SQLite database to track and update
the validation errors found in NU-AGE data.
The wrapper is based on SQLAlchemy (see 3.2.2) and uses the declarative
approach to define three models used to store the information needed to
build the reports:
• RecCentre, which hosts information regarding the recruiting centers;
• Questionnaire, which allow to link questionnaire IDs, the qid attribute
we saw before, with questionnaire names and their correct ordering;
• VR, which is the database counterpart of the Python class we encoun-
tered in the Rules library.
As usual, let’s start with an example of the code. VR models are defined
in DBWrapper as follow:
1 class VR(Base):
2 """
3 Validation Result (VR) mimicking ad db level to store
↪→ Validator produced VRs.
4
5 """
6 __tablename__ = ’validation_results ’
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7 __table_args__ = (UniqueConstraint(’pid’, ’qid’, ’
↪→ record ’, ’rule_id ’, ’cid’, ’variable ’, ’value’,
↪→ name=’_error_code_uc ’),
8 {’sqlite_autoincrement ’: True}
9 )
10 id = Column(Integer , primary_key=True)
11 pid = Column(Integer , nullable=False)
12 qid = Column(Integer , ForeignKey(’questionnaires.qid’),
↪→ nullable=False)
13 prog_id = Column(Integer , nullable=False)
14 record = Column(Integer , nullable=False)
15 rule_id = Column(String , nullable=False)
16 cid = Column(Integer , ForeignKey(’recruiting_centres.
↪→ cid’), nullable=False)
17 valid = Column(Boolean , nullable=False)
18 help_text = Column(String ,)
19 variable = Column(String , nullable=False)
20 value = Column(String , nullable=False)
21 authorized = Column(Boolean , )
22 authorized_on = Column(DateTime)
23 active = Column(Boolean)
24 inactive_from = Column(DateTime)
If you bother going back to the VR definition in the Rules library (4.2.4),
you can realize that most of the attributes are identical, except for 4 new-
comers, namely:
• "id", the progressive id of the stored VR;
• "cid", which refers to the id of the center stored in the RecCentre table;
• "authorized" and "authorized_on", which track if a VR was authorized
and when;
• "active" and "inactive_from", which track if a VR happened in the last
validation, so it must be considered active or, alternatively, when we
saw it the last time.
Before proceeding, let’s focus a moment on attributes "qid" and "cid",
which are declared differently from other attributes, as you can see in the
code. That’s because they are foreign keys pointing to records contained
in tables Questionnaire and RecCentre, respectively. Foreign keys are the
database parallel of the keys we saw in EpiData: unique ids that allow to
link together information contained in otherwise unrelated tables.
We should also keep in mind that some error may occur when interacting
with SQLite, and we don’t want to have truncated or invalid data in our da-
tabase. Luckily, databases allow for rolling back changes done in the current
session, and SQLAlchemy supports this function. Within Validator, there’s
a small piece of code that monitors queries execution and, if any exception
is raised, rolls back the changes and propagates the original exception for
debugging. In this way, the database content is preserved from damage.
pdfwrapper Having validation results stored in a database is useless un-
less you get them out in some usable form. When we started thinking about
which was the most useful way of telling centers what went wrong in the
validation using a non-modifiable format, the first option we thought of was
obviously a PDF file. Everybody has a PDF reader installed nowadays, and
the fact of being a read-only format granted us that information would have
reached the final user untouched. The de-facto standard for PDFs creation
in Python is ReportLab (ReportLab Website), an easy to use library with
thousands of tutorials available online.
Cutting a long story short, what you need to do to create your PDF is
defining the paper format you want to obtain and then fill what ReportLab
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Figure 7: Example of test PDF report produced by PDFWrapper. Test page detailing
errors and missing codes in the Admission 2 Questionnaire, ordered by
PID and progressive id of the question.
documentation defines a "Story": a list of elements that will then be assem-
bled together, being them images, titles or whole pages. PDFs produced by
PDFWrapper are divided in two separate section with different aims. The
first section is made by a summary page that gives a bird’s view on the
number of VR in the database, subdividing them in active, inactive, valid,
invalid and authorized. The second section, on the contrary, hosts a long
list of tables, two for each questionnaire, with the first containing detected
errors and the second variables where missing codes are present. This sec-
ond table is there for the sole purpose of having recruiting centers "touch"
the amount of missing codes they’re using, and double-check if they simply
didn’t remember to go back and fill the missing data.
Once all the elements are in the Story, ReportLab combines them produc-
ing a ready-to-use report ready to be sent back to the centers, a screenshot
of which can be seen in Figure 7.
excelwrapper PDF reports are wonderful to display information, but
when it comes down to provide an even minimal interaction with the data,
they are quite poor. They are not designed to do so, after all! What is the
most adopted format/program in the world for working with tables and
data? Without any doubt, the first place goes to Excel.
Python has several libraries to interact with Excel files, but at the moment
of writing the code only openpyxl (openpyxl Website) offered compatibility
with the new XLSX format, and was thus adopted for our wrapper.
For most part the of job what ExcelWrapper does is identical to the job
done by PDFWrapper, the only difference being that instead of different
tables we here have different worksheets. Nonetheless, there is an impor-
tant distinction to be done: each worksheet has two additional columns if
compared to the tables built by PDFWrapper: Authorize and Reason. As
previously said, these columns are used to allow centers to report back false
positives, and part of the code inside ExcelWrapper is devoted to reading
back these authorizations, verify if they are valid and, if the answer is affir-
mative, update the database accordingly. Once authorized, failing VRs will
be ignored in following validations.
A screenshot of an Excel test report can be seen in Figure 8 on the next
page.
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Figure 8: Example of test Excel report produced by ExcelWrapper. Results for each
questionnaire are splitted in different worksheets, while each row repre-
sents a VR. You can clearly see here the columns "Authorize" and "Reason"
used to report false positives.
4.2.5 NU-AGE Validator - How it works
We spent quite a lot of time (and pages) in detailing the components upon
which Validator is built, ranging from questionnaires loading to validation
and reports building. It is now time to see how these small pieces work
together to obtain the final result.
As many sci-fi films have proved you, serious people do work writing
commands in a small black box called bash (honestly, bash in not the only
option, but this would end up in a really, really, long discussion). Validator,
being a respectable software, can only be invoked in this way. So, writing
validator.py
and pressing enter will show all the options you have to launch validator.
The first distinction the software asks you to do is if you want to validate
new data or read back authorizations from an excel file. Obviously, required
arguments do differ depending on the task you need to do. For brevity, we
will ignore the part regarding authorizations, and stick with validating new
data.
The list of parameters you need to specify in this second case is the fol-
lowing:
• rules_folder: where Epidata / YAML files to be use to create the Ques-
tionnaireSet are stored;
• data_folder: where the files containing datasets referring to the ques-
tionnaires are stored;
• database: path to the SQLite database;
• rec_center: the progressive ID of the recruiting center to which data
belongs to. This is a safeguard agains loading the wrong data by
mistake;
• external_checks: path to the file where ExternalRules are defined;
• metadata: path to the file where the mapping between Questionnaires
and datasets names and questionnaires order is stored;
• promote_list: path to the file that contains the list of variables that
cannot have missing values. If a variable in this list has a missing
value, it is listed as an error;
• output_prefix: a string prefix to prepend to the output files. This is
handy when the destination folder of the reports is identical indepen-
dently from the center under analysis.
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Now that you have all your arguments set, you press enter. What is going
on next? First of all, the program fetches, starting from the center id you
provided, the name and location of the recruiting center, displays them for
verification and awaits your authorization to proceed.
Once authorized, it proceeds by parsing questionnaires and checks defi-
nitions with EpiDataParser and YamlParser and building the Questionnaire-
Set. Then, metadata are loaded and the number of listed questionnaires in
the file is compared to the number of questionnaires within the Question-
naireSet. If they match, the program continues loading into the database
any new questionnaire the metadata may contain. Then, it’s ExternalRules
turn to be loaded and injected in the questionnaires. With this operation,
the QuestionnaireSet is ready to be used to validate data.
Validator then scans the directory containing the datasets, looking for
files with extension ".txt", ".xls" or ".xlsx", the three formats the software
supports. Depending on the format, different Pandas (see 3.2.2) methods
are used to load the data in memory while creating an index containing all
the PIDs present in the files. This index will be used in the succeeding steps
to validate subjects one by one.
The first real step of validation is the inactivation of all the stored VRs
regarding the center under analysis. Then, iterating over the subjects in-
dex, data regarding each subject are extracted and progressively validated
against the Questionnaires. Once a Questionnaire is validated, VRs are
compared to those stored in the database: if a record is already present
it is flagged as active and updated, otherwise a new record is created from
scratch. When all subjects are validated, a DBWrapper method is invoked
to set the inactive_from field of all newly inactive records to the current
date and time. Finally, the session is committed and changes flushed to the
database.
The last step is building the reports. Thanks to the wrappers that take
care of the heavy lifting, building exports requires four lines of code:
1 report = PDFWrapper(args.database [0], args.rec_center [0],
↪→ promoted_variables)
2 report.build_report(args.output_prefix [0])
3
4 excel = ExcelWrapper(args.database [0], args.rec_center [0],
↪→ promoted_variables)
5 excel.build_report(args.output_prefix [0])
where the arguments are easily recognizable as the parameters we pro-
vided when launching the software.
The last validation of Italian data reached the whooping number of 147710
active VRs, that gives a pretty good idea of the quantity of work Validator
does every time it is launched. The amount of time the process will take
is not easily predictable, being heavily dependent on the number of errors,
thus VRs, produced which is in turn function of the data amount and quality.
To give you at least an idea of the order of magnitude, the Italian data
validation reported above took about 13 minutes.
There’s still plenty of room for improvement in the code that would re-
duce its running time, maybe consistently. However, Validator is just at the
first iteration, a beta version if you want to define it so, which, as is, is
already enough to answer NU-AGE needs.
4.2.6 Validating continuous data, without fixed boundaries
Not all data are categorical. Many important parameters are indeed contin-
uous values, which cannot be validated just setting rules because of their
innate characteristic: coming from all but predictable biological entities.
Data regarding blood pressure, height, weight and most of the values
obtained via fresh blood assays can’t be cleaned defining hard limits and
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Figure 9: Probability density function plot of a parameter suffering from systematic
errors. A center shows striking lower values for this parameter in all its
subjects, while single outliers coming from several centers appear at very
high values on the X axis.
throwing away everything that falls out. What we initially tried to do in
NU-AGE was getting in touch with medical doctors in the 5 recruitment
teams to understand if setting limits to these values was possible and if
a consensus may have been built on which were the correct boundaries.
However, it rapidly became clear to us that a sharp bound could not be
defined.
Blood values, such as glucose and so on, have healthy ranges, but they
do change from country to country. To partly overcome the problem, we
collected these ranges, combined them to obtain a "general" interval of ex-
pected values and then set the data entry interface to accommodate all the
values contained within this range. If a value fell outside, a simple warning
was given and data entry allowed to continue. This was probably not the
tightest possible way to proceed, but at least protected us against non-sense
values.
Nonetheless, the described approach can only be used when a reference
range exists. DXA and Nutrients, for example, are not so fortunate, and
require a different treatment. Since in this context validating a single value
is not possible, focus must me moved on validating the whole distribution of
the values, and that’s exactly what we did in NU-AGE. When the data entry
of T0 values was completed, we plotted the distribution of the continuous
variables looking for outliers. As you can see from Figure 9, its is rather
easy to spot a systematic difference: one center do has striking lower values
for this parameter in all its subjects, and single outliers from various center
appear at very high values in the X axis.
But, you may argue, this is a manual process, how to automatize it? Val-
idator could do the job? Automatic outlier detection is an area in statistic
that is still highly debated today. There are many methods, i.e. elliptic en-
velope fitting and One-class SVMs, but there is no general agreement on
which represents the best answer to the problem, also because the answer
depends on the distribution the values under analysis do have. An Elliptic
Envelope can do wonders with an unimodal gaussian distribution, but is
rapidly overtaken by SVM approaches when things gets worse.
After some unsatisfactory initial tests in which we tried to find a "one-
solution-fits-all" answer, we decided to leave automatic checks of this kind
out of Validator. We instead computed for each continuous variable the 5th
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Figure 10: NU-AGE variables documentation file. Each line represents a variable
and provides information regarding the source dataset, logical grouping
with other variables (if any), variable type, and so on.
and 95th percentile of its distribution and used them as expected ranges in
simple InRange checks in Validator, for both T0 and T1 data. This approach
may seem coarse at first glance, but it has proven to be a good compromise
between false positives and false negatives rates, allowing to solve otherwise
difficult to detect errors. The downside is that it’s data dependent: you can’t
transfer the ranges obtained in NU-AGE to other studies, unless the same
population and instruments are used. Independently from the success this
approach had, there’s a rule of the thumb that every person should keep
in mind: when complex data are at play, nothing is better than a trained
person in checking them. He or she can be helped by automatic systems
such as Validator, but a final glance by a human eye is always needed.
4.2.7 Crunching everything - document to rule them all
Databases full of precious and extremely expensive data can be transformed
into junk if nobody can understand how they’re organized. It is probably
the most boring and overlooked task in scientific research, but documenting
the data is a key step to allow their usage in the long term. It happened to all
of us: a thing you perfectly remembered until the minute before, then you
can’t recall even the tiniest piece of it. That’s why the meaning of variables,
the keys used to encode them and, in a broader sense, all the metadata, data
about the data, that may be put at good use in the future must be clearly
written down and made available to all interested parties.
In NU-AGE we followed this "creed" from the very first moment. As soon
as data have begun to flow inside the database, questionnaires structure
and checks were combined leveraging Validator parsers and relevant infor-
mation stored in a Excel file, visible in Figure 10, ready to be exploited by
data analysts. Each line in the file contains a variable – the order is given by
its appearance in the QuestionnaireSet – and details from which dataset it
comes from, any logical grouping with other variables, the type, and so on.
But this is just half of the story. What it is also important to know is how
anomalous values should be treated: there’s a reason for them, and thus
they should be kept in the dataset, or we must consider them an outlier to
be discarded? Here the database we’re building with Validator will come
into play. Once the validation will be deemed complete, authorized VRs
along with their reason will be extracted and made available in a yet to de-
fine format to NU-AGE partners. This will empower a rational decision on
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removing subjects from the cohort, improving the usual custom of throwing
away everything that doesn’t fit the initial idea of the data.
4.3 nu-age - the @bologna database
At the beginning of 2014, when the data started to grow in the database
and Validator reached a stable enough development point, we realized that
having a copy of the NU-AGE database hosted in Bologna would have facili-
tated the validation work. Nonetheless, deploying an infrastructure capable
of managing the data and ensuring their security against external threats,
while keeping them available for the authorized staff, is a complex task that
embraces many different domains.
4.3.1 Why?
The "why" behind this decision must be looked for in the following points:
• reduce the overhead. At that time we were pre-processing every up-
date of the data twice: to validate them with Validator, and to send
them to the dbnp (see 3.3.4).
• reduce the workload on the TNO. Every iteration of the data was pro-
cessed and sent to be loaded in the database, that was instead sup-
posed to store only their final revision.
• tracking. Dbnp does not support data versioning, mainly because it’s
focused on storing clean data only. Nonetheless, having older version
of the information is important while you improve them, at least for
comparison.
• reduce time-to-database. The time a single bit of information takes
between being entered in the data entry interface and reaching the
database ready to be queried is wasted time and should be reduced as
much as possible.
All these point could have received an answer with a database in Bologna:
single pre-processing, versioning, shorter time to database, and less work on
top of TNO’s shoulders.
4.3.2 Which database?
Database is a catch-all word that means a lot of things. Microsoft Access is a
database, but is not exactly what you imagine when talking about databases.
PostgresSQL is a RDBMS that could do the job, but it’s just the shelf where
to store information, but what about regulating access to this shelf, let alone
support an easy and friendly access?
What we were looking for in reality was a whole platform for data ex-
change, not just a database, but a front-end to be made available online
for people to access the data and administrator to monitor this access. We
searched quite a lot to find a suitable candidate, and we eventually found
LabKey (see 3.3.5). We quickly deployed it on a virtual machine for testing
purposes, and soon realized that it was exactly what we were looking for.
4.3.3 Database deployment
Deploy means having a server to deploy into. However, we didn’t have a
server available, and we also lacked the skills needed to harden (a computer
science term to say "make more secure") it. We thus started a profitable
collaboration with the University IT Department, that provided us with a
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Figure 11: NU-AGE main page in LabKey platform. From here users with enough
privileges may access the data subdivided by center, the datasets contain-
ing all the subjects, as well as the study admin panels.
virtual machine in their virtualized infrastructure in no time, and helped
us in ensuring its integrity. These efforts eventually ended up in a 10 page
long document analyzing all the weak points to be addressed to increase
and maintain in time the security level of the resources, reaching a level
assimilable to what it is normally requested by the ISO 27001 certification
(http://www.27000.org/), the de-facto standard of data protection and in-
tegrity. We cannot provide here the details about all the steps undertaken
to secure the server for obvious reasons. However, every component used
by the interface, PostgreSQL, Tomcat and the operating system itself were
analyzed and patches applied to reduce the risk of external threats.
LabKey, through Tomcat, publishes a web interface for users to access the
platform resource via any common browser. Appropriate ports were opened
to provide encrypted (https-only traffic) access to authorized personnel, and
strict policies applied for password creation and expiry.
4.3.4 Database description
The access to the database, if correctly configured, is extremely easy. Once
connected to the correct url, you’re presented with the platform home page,
from which the area dedicated to NU-AGE, visible in Figure 11, can be
accessed. Through a menu, it is possible to select the subfolders hosting
the data separated by center (see Figure 12 on the next page) and the doc-
umentation, which is made by a set of wiki-style pages containing all the
information needed to navigate the data (see Figure 13 on page 54) .
Lastly, If you’re granted access to, you can access the location where the
whole study is stored. LabKey provides numerous facilities to help dealing
with longitudinal studies, ranging from monitoring datasets filling, to as-
says management, automatic subdivision of enrolled subjects in sub-cohorts
(i.e. cases / controls) depending on the entered data, values plotting and ad-
vanced querying. In Figure 14 on page 55 you can see the so-called "Study
Navigator", a page detailing the number of records the system contains for
each dataset at each timepoint.
4.4 nu-age systems biology
One of the techniques that immediately pops out of a researcher’s mind
reading the NU-AGE project is, probably, systems biology. With the plethora
of gathered data, some of which proxying the functionality status in funda-
mental physical and cognitive systems, building models on the most dis-
parate interactions may be theoretically possible. But, are we there already?
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Figure 12: NU-AGE menu in LabKey platform. From here users with enough priv-
ileges may access pages regarding specific centers and NU-AGE docu-
mentation.
4.4.1 Where to start the journey from
The 1-year diet intervention is the planet around which the whole project
orbits. We can’t start even only speaking about systems biology in NU-AGE
without understanding the diet first, in terms of:
• Diet was really followed by the subjects (compliance)?
• Which subjects in the diet group did not follow it?
• Controls were really good controls from a nutritional point of view?
• Controls were still good controls after 1 year, or they changed their
habits?
These are difficult to answer points, but ignoring them could have severely
undermined the study power and outcome. The reason lies in Figure 15
on page 56, and in assessing if it depicts the real situation or not. But let’s
go one step back. The ideal starting point in an intervention study is a
condition were subjects that in the future will be enrolled in the diet and
control branches do behave identically. That’s the reason behind random-
ization, after all. Imagine to represent the NU-AGE diet as a point in a
n-dimensional space, where the n dimensions are the nutrients dietitians
take into account to evaluate NU-AGE subjects prior to the inclusion and
throughout the project. Following the same approach, the diet each subject
was following before being enrolled can be transformed in a point in the
same n-dimensional space. In the ideal situation, subject’s points should lie
far away from the NU-AGE diet, possibly well clustered together. Keeping
following our "ideal situation case", half of the people are randomized in
the diet branch, and follows the intervention for a year. In this timeframe,
their diet, thus their points in space, will hopefully move toward NU-AGE,
as show in figure 16 on page 56. At the same time, controls does not alter
their original nutrients intake and keep their points as they were originally.
This is a very fabulous tale, but it depicts the real situation? All diet sub-
jectd really followed the diet, and none of the control subjects changed their
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Figure 14: NU-AGE study navigator in LabKey platform. From this panel, autho-
rized users can have a precise idea of the completition status of each
dataset composing the study.
habits in response of only having heard about a "healthy diet" once? Be-
cause, if one of these assumptions doesn’t hold any longer, we may lose all
the power the study has or, worst, draw wrong conclusions from the data.
This was the question fiddling in our mind when we first thought about
how to verify these hypotheses. However, we were quite sure that the n-
dimensional space was the right direction to point at. Which is the best tool
to pull down n-dimensional spaces (each one representing a variable) to two
or three dimensions? PCA, of course! We did a PCA on T0 nutrients data
from all the centers and results were far from being what we expected at all.
What will follow in the next paragraphs is an analysis of the first four
components obtained applying PCA our data. A plot of the fraction of ex-
plained variance by each component is visible in Figure 17 on page 58, from
which you can see that the first four components account for roughly the
60% of the variability. However, the rest of the figures are not exactly what
readers are used to expect when talking about PCA, so I will spend a couple
of lines explaining them. Let’s start with Figure 18 on page 59. The plot on
the left shows the loading values for the first component. Loadings are num-
bers defining the weight each variable has in defining the final value of a
given component for each subject. Positive loading will pull the component
final value to positive values, while negatives ones will have an opposite
effect. How strong this pulling is is defined by the absolute value of each
loading. Going back to the plot, on the Y axis we have all the variables,
while their loadings are plotted on the X axis. What we can glean from
this graph is that the first component seems to be pretty generic: we have
a single positive loading – the percentage of energy coming from carbohy-
drates – while all the others are negative. Probably, the component value
depends simply on the total income of food each subject eats. Let’s focus
now on the right part of the figure. Here you have 5 histograms showing the
distribution of the values of first component divided by center (sub-plots)
and sex (color). The green bar represents the point were a subject exactly
following the NU-AGE diet would lie in the chart. Almost all distributions,
independently by sex and center, peak around the ideal diet. The only cen-
ter that is skewed to the right, thus towards positive values, is UNIBO. This
observation nicely fits with the plot on the left: the only positive loading is
the amount of energy coming from carbohydrates, and you know, Italians
do love pasta!
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Figure 15: NU-AGE Systems Biology - The ideal enrolled subjects’ situation at T0.
Future control and diet subject have a similar diet which is far from NU-
AGE one.
Figure 16: NU-AGE Systems Biology - The ideal enrolled subjects’ situation at T1.
After the one-year intervention, subjects following the diet branch move
their own diet towards NU-AGE one, while controls keep their original
positioning.
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The second component, visible in Figure 19 on page 60, shows instead a
different behavior. We have three important negative loadings, all related
to fats (fat, saturated fats, MUFA-PUFA), against a single positive loading,
which is again the percentage of energy obtained from carbohydrates. This
time the component tries to discriminate between sugars versus fats con-
sumption. Nonetheless, distributions are still pretty similar in all the centers,
each peaked around the idea diet.
The third component, visible in Figure 20 on page 61, eventually behaves
differently from the previous ones. This time it’s protein income (fr-prot-
energy variable) against all the other nutrients plus the difference between
needed and introduced energy (last variable in the chart, fr-diff-energy). In
this case, the charts on the left start to show some differences.
Fourth component, Figure 21 on page 62. Things are getting fuzzier here,
and explaining the rationale the PCA is trying to extract is increasingly
difficult. We have several nutrients with positive loadings against a single,
very important in absolute value, loading: alcohol (fr-alc). We named this
component "health conscious versus non caring", but probably a better name
would have been "No alcohol vs alcohol". Yet again, most of the centers
behave similarly, with the exclusion of WULS (Poland) that seems to have
enrolled subjects with a lower preference for alcoholics. Still, distributions
peak are around the ideal value.
We indeed plotted up to the 6th component, but after the 4th it was really
hard to understand their meaning. In any case, given that these first four
plots do account for more than the 60% of the variability, they already give a
clear picture of the trends in the data. We now know that NU-AGE subjects
lie around NU-AGE diet at T0, but we still miss information on how far and
spread they are.
An initial answer to this question could be given by plotting in a three
dimensional scatterplot the first three PCA components, that should give
us an idea of the relative positioning of each subject with respect to NU-
AGE. The result is shown in Figure 22 on page 63, which contains four
scatterplots of the same data, rotated at four different angles. The first take
home message this representation gives is that subjects form a cloud that, at
one side, contains the "ideal diet" itself (represented by axes crossing point).
The second message is that the distance between each point and the diet
greatly varies, and we thus can’t consider all the subjects in the same way.
Third message: the cloud is formed by an almost identical number of diet
and controls, are they clustered by branch or not? We should have a way
of evaluating these distances to better weight the data obtained within the
project.
These initial analyses propelled a inter-center effort, mainly driven by
UNIBO, to define a compliance index for the NU-AGE diet. Compliance
indexes already exist, but are pivoted on guidelines that are different from
what defined by the consortia. We thus decided to implement a new index
specifically based on the fortified diet that is the key point of the whole
project. From a theoretical point of view, this is not complex: dietitians use
the same nutrients intakes we used in our PCA to evaluate the progress
subjects do towards established daily incomes. A simple euclidean distance
between optimal values and each subjects intakes could give us a coarse
index to start with. However, there are still open questions that must be
addressed:
• not all nutrients have the same importance, and should weight differ-
ently in the index;
• optimal incomes are not symmetrical, i.e. it is far better to be 10 units
below the threshold value for sodium than 10 units above it;
• People do cheat normally. When talking about diet and health, they
cheat even more.
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Figure 17: PCA on Nutrients Data - Fraction of explained variance by each PCA
component. The first 4 components explain ~60% of the variance.
I’m sorry to say that, at the time of writing of this thesis, the consortia
is still discussing the best approach to solve these issues. The last point
in the list can be somewhat solved asking dietitians their gut feeling about
how trustworthy the data reported by each subject were, but this is far from
being a "scientific" approach. On the contrary, to address the other two
issues we started a very long work of revision of the literature to come up
with a consensus about which nutrients, among the monitored ones, should
our index be more focused upon, and how to deal with the lack of symmetry
in some of them.
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Figure 22: The NU-AGE Cloud. This plot shows a series of 3D scatterplots based
on the first three principal components obtained in the described PCA
approach, where each plot position is given by tis values for the first 3
principal components. The point where the three green axes intersect
themselves represents the point where a subject exactly following the
NU-AGE diet would lie. The four subplots are different rotations of the
same plot.
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4.5 geha and the epistasis
GEHA main aim was to understand the genetics components, if any, of
longevity. In particular, our lab was in charge of part of the mitochondrial
DNA sequencing and analysis.
4.5.1 Obtaining the sequences
In total, GEHA completely sequenced ~1200 mtDNA samples, 200 of which
were done in Bologna, while the rest was sent to the BGI (China) to be
processed. However, analyzing the FASTA files obtained by the two labo-
ratories, it was clear to us that samples sequenced in China had a higher
number of mutations, most of them recurring at fixed positions, support-
ing the idea of problems in the sequencing and/or assembling steps. Since
raw data from the sequencer were available, we decided to reassemble them
from scratch.
The first step was to build a pipeline capable of reading and processing
the raw data. From private communications with the BGI, we knew that
they pipeline was based on Phred and Phrap, well known command line
softwares in this field. To better understand the issues BGI incurred in and
possibly solve them we decided to adopt the very same tools.
Phred and Phrap work together to read data coming from the sequencer,
the chromatograms, call the bases and assemble the contigs. In general,
the pipeline successfully assembled most of the sequences, and only small
refinements in well-known troublesome positions (i.e. C-stretches) were
needed. For a small subset of them, however, the automatic approach
proven to be insufficient.
Fixing the errors
Sequences failing automatic assembly mainly came from sub-optimal sam-
ples, characterized by quality values lower than the average. In the assem-
bling phase, parameters controlling how quality values are assigned and
the minimal thresholds for a read to be included when building contigs
have obviously a critical importance. In our initial setup, reads with length
below expected due to low quality issues were automatically discarded.
This approach represents the golden standard in an ideal situation, but
can severely hamper the final result when, for various reason, the sequenc-
ing step doesn’t perform optimally. Mitochondrial DNA sequencing is well
know to be a tricky challenge due to its peculiarities, such as the very high
number of homopolymers. To accommodate these lower quality sequences,
discarded reads were manually analyzed and pipeline parameters tweaked
to allow a less stringent filtering, ultimately leading to complete sequences.
Particular care was then used in manually revising the mutations harbored
by these samples, since more relaxed parameters in the assembly step can
cause the number of errors to surge abruptly. In edge cases, sequences were
manually checked base by base by a trained researcher.
How to evaluate the quality of the final product, the sequence? Obtained
sequences were continuously aligned with ClustalW (then ClustalOmega)
against the mitochondrial reference sequence (rCRS, Anderson et al. 1981;
Andrews et al. 1999. It wasn’t possible to adopt RSRS since the whole
GEHA project was based on rCRS) to monitor their quality, thus providing
a stable guide to tweak the pipeline parameters towards an improvement
of the reliability of the process, since detecting much more variability that
expected – and described in literature – would immediately switch a red
light on. We can call this process a parameter optimization process, where
the measure leveraged to evaluate the fitness is the sequence quality and
reliability.
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Comparing the sequences obtained by UNIBO starting from raw data
against the initial version allowed to detect ~700 errors, some of them recur-
ring in many samples. Ultimately, the work done allowed to significantly
increase the quality of the data, lowering the noise level that could have
severely impacted on the statistical analyses.
4.5.2 Analyzing them
FASTA sequences are a step toward data analysis, but they are still a sort
of "raw data", albeit reaching them means a significative amount of work.
How to proceed further?
A routine analysis that also doubles as quality check is haplogroup as-
signment (Salas et al. 2005). In 2013, we published a tool called HaploFind
(Vianello et al. 2013) that automatically does this task, accepting as input
mtDNA sequences in FASTA format and giving back reliable assignments
based on the statistical analysis of the sequences available in GenBank, us-
ing PhyloTree (van Oven et al. 2009) as a scaffold. Yet, the first step for
assigning an haplogroup is to know which mutations the sequence hosts to
map them on the tree. HaploFind allows to export, along with the assigned
haplogroup, SNP discovery results in various formats ready to be analyzed.
For our analysis we started from the Excel output HaploFind provides,
which is basically a long list of rows each one reporting the sequence id
of a sample in the first column and its mutations in the second. Other
information are also available, but are out of the scope of this thesis. We
melted the information contained in the export, ending up with a matrix in
which every row represented a subject and every column a mutated position.
At the crossing between a subject and a position the nucleotide at that given
position in that given sequence is reported.
Where to go from here? In 2013 we published a paper (Raule et al. 2014)
describing the result of a initial set of analyses on these samples, where we
failed to identify the association of single SNPs to the longevity phenotype,
but we indeed detected significant signals when taking into account com-
plexes as a whole, i.e. OXPHOS complexes. What were we seeing there?
One possibility was that these mutations were interacting with each other
sprouting in the phenotype of interest. In other words, epistasis may have
been at play. For quantitative phenotypes the epistatic effect was defined
by Fisher R.A. back in 1918 as a deviation from additivity in the contribution
different loci have on the phenotype. For qualitative phenotypes, epistasis may
be defined as the phenotypic effect two loci have only if both are present.
Epistasis can be detected with different approaches, as thoroughly de-
scribed in literature (Cordell 2002; Emily 2012; Moore 2015; Moore et al.
2014; Ritchie 2015). Nonetheless, we decided to apply new approaches to
the problem, starting with a method based on entropy analysis.
Detecting epistasis with entropy
We’re not speaking of entropy in chemistry terms here, but in terms of infor-
mation theory (Shannon 2001), where it is a measurement of the amount of
information a signal carries. In our case, the concept can be rephrased as the
amount of information a mutation (or a combination of) contains regarding
the fact of being long-lived or not. This value, for the scope of our analysis,
can assume values between 0 and 1, since we can only choose between two
states (long-lived/control).
Figure 23 on page 67 packs in a single plot all the results we had from
this technique. On the Y axis there are the ~1200 GEHA sequences, while
the X axis hosts the mutated positions, ordered by descending value of epis-
tasis from left to right, with the blue shadow graphically representing this
trend. The crossing between a sequence and a mutation is white colored if
the sequence harbors the mutation, black otherwise. Red arcs connect muta-
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tions that, as a couple, have a entropy level high enough to enter in the top
500 informative couples, where the opacity of the line is in function of the
entropy value. What can we get from this figure? Several interesting thing,
to be honest:
1. Mutations present in almost all the samples, denoted by white bands
in the graph, don’t encode any information, since controls and long-
lived are equally present in the dataset;
2. We have many short arcs at the left side, ending up in a red glob.
There’s nothing interesting in these: we’re on the left side of the graph,
where the entropy level of each mutation alone is already high, no
surprise that combining two of them we have a strong couple;
3. Long arcs encompassing all the plot, however, begin to be interesting:
a strong mutation together with a weak one enters in the top 500 cou-
ples;
4. Eventually, the really interesting arcs are those that start and end in
weak mutations, which together reach the top 500. Something must
be going on there!
With this preliminary analysis we obtained evidences supporting the fact
that some deviation from additivity do exist in the longevity phenotype,
and we should carefully look into it. This entropy-based approach, albeit
promising, do had some severe limitations:
• due to the formalization of the algorithm, it is really difficult to scale
up in the number of simultaneously analyzed SNPs (to be read also
as: increase the length of the mutations signature) both from a formal
and computational point of view. The reader should keep in mind
that epistasis analysis is a indeed a NP-hard problem, a problem that
has no solution other than testing all possible cases to choose the best
among them.
• it is not possible to compute a significance for entropy values.
• it is not exactly answering our question.
Regarding the last point, this approach guarantees to find the most infor-
mative couple, while our aim was to find the probability of a subject being
long-lived given a signature of interacting mutations.
Bayesian approaches for epistasis detection
We can formally rewrite the sentence above, probability of a subject being long-
lived given a signature of interacting mutations, as
P(C|E) (1)
where E is the set of mutations in epistasis. Exploiting Bayes’ theorem, we
can rewrite the formalization as
P(C|E) = P(E|C) ∗ P(C)
P(E)
(2)
where P(E) can be then further divided in its components, thus obtaining
P(C|E) = P(E|C) ∗ P(C)
P(E|C) ∗ P(C) + P(E|N) ∗ P(N) (3)
where P(N) represents the probability of not being long-lived. This proba-
bility should in theory be estimated from GEHA controls, a part of which
may, at least from a genetic point of view, be fully fledged future centenari-
ans, thus causing a bias in our evaluation. To reliably estimate the fraction
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Figure 24: Trend of 90+ people percentage in the population of countries partici-
pating in the GEHA project from 1960 to 2013. Data source: Eurostat,
December 2014.
of long-lived (in GEHA, "long-lived" subjects are 90+ subjects) in the general
population we exploited the demographic data freely provided by Eurostat.
As expected, this fraction was very low, but greatly varied among different
countries and time periods, as visible in Figure 24. This variance must be
taken into account, since it could cause biases when analyzing projects such
as GEHA, which collected samples from different countries.
To overcome the issue given by the variability of the fraction of centenar-
ians, we switched our formalization from probability to odds (the two are
exactly the same, being O = p1−p ) obtaining:
O(C : N|E) = ∧(C : N|E) ∗O(C : N) (4)
where
∧(C : N|E) = P(E|C)
P(E|N) (5)
With this formalization we can separate our knowledge about the general
population (term in O) by the information obtained through our observa-
tion (term in ∧), which is our relative risk. For GEHA, since obtaining a
solid estimation of the parameter O (also called prior in Bayesian statistics)
applicable to the whole dataset proved to be impossible given the variability
previously described, we decided to ignore it. The price to pay for this is
easy to tell: our estimate will only be based on the relative risk and will thus
be valid only for the GEHA cohort. Nonetheless, this can also be seen as a
strong point: anyone knowing the intrinsic risk of his or her population can
readily obtain the absolute risk for the population simply multiplying it by
the relative risk we estimated.
Last but not least, we wanted a measure to gauge how strong our claims
were. Unfortunately, the approach just described doesn’t allow to compute
p-values for the obtained statistics. We can instead compute the Bayes factor,
which is formally defined as
K =
P(D|H1)
P(D|H0) (6)
and represents the ratio between the probability of the data given the al-
ternative hypothesis divided by the probability of the data given the null
hypothesis, or, in our context, between having and not having an epistatic
effect between mutations. Higher the Bayes factor value, higher the proba-
bility of our model: a bayes factor of 3 means that the model with epistasis
is three times more probable that the model without it. Kass gave in 1996
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Table 6: Threshold values for K interpretation
K Strength of evidence
1 to 3 Not worth more than a bare mention
3 to 20 Positive
20 to 150 Strong
>150 Very strong
a scale of interpretation for K values (Kass et al. 1995), visible in Table 6,
where values greater than 3 are considered "Positive". Indeed, a Bayes fac-
tor of 3 is the threshold we used to flag our results as significative.
When applying the same test multiple times to the same dataset, the prob-
ability of obtaining false positive results increases accordingly. For this rea-
son, results must then be corrected for this "multiple testing" procedure.
The most famous correction is probably the Bonferroni correction, after the
name of the Italian mathematician Carlo Emilio Bonferroni, that requires to
test each hypothesis at a significance level of α/n, where α is the desired sig-
nificance level of the whole set of tests and n the number of performed tests.
There are also more relaxed corrections, such as the Benjamini-Hochberg
procedure, which aims to control the false discovery rate (FRD), usually pre-
serving more true positive results in spite of a relatively small number of
"accepted" false positives.
A strong point of our approach is that its results don’t need to be corrected
in this way, since the correction is applied within the test itself. In Bayesian
approaches, it is possible to inject in the tests previous knowledge about
the data you’re going to analyze, with the so-called priors. For example, the
O term we decided to ignore in Equation 4 on the preceding page was a
prior. To avoid the necessity of multiple testing correction, we analyzed our
sequences to determine the probably of having in any given position of the
mtDNA the wildtype allele, the second most frequent allele, the third and
the fourth and used it as a prior in our approach. We are thus telling the test
in advance how many mutations it should expect, thus correcting the final
result. At the same time, priors allow us to reduce overestimation biases
due to small sample size.
4.5.3 Single SNP association
New methods needs to be tested, and we thus tried to identify single SNP
associations in our dataset as a test bench. We analyzed two possible repre-
sentations of the data:
• At amminoacidic level (AA), using non synonymous mutations;
• At nucleotide level (nt), using all types of mutations.
In both cases we had significant results in terms of Bayes Factor, Odds Ratio
(a measure of association of a mutation to a given phenotype) and Risk Ratio
(a measure of how the risk of occurring in a condition increases having a
given mutation).
Figure 25 on the following page shows the result for the analysis at AA
level, with the log of the odds ratio on the Y axis and the corresponding
Bayes factors on the X axis. We have some solid evidences here, with Bayes
factors as high as 14.5 and log odds ratio above 3 for mutations occurring
in ATP6 and ND6, both linked to the OXPHOS chain. It has to be noted
that the distribution of the point is symmetrical due to the inner working
of the odds ratio: an allele (or AA, in this case) is as strong as associated
to a phenotype as other alleles (or AA, in this case) occurring at the same
position are associated to controls. Figure 26 on page 71 shows the same
result but in terms of risk ratio. Here the symmetry in the plot is lost: a
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Figure 25: Bayes Factor versus Log Odds Ratio - non syn, AA level. The red and
green vertical bars visualize the first and second threshold value for Bayes
factor evaluation, where above 3 means positive strength of evidence.
Mutations falling in the red and green part of the graph are linked to
controls and long-lived, respectively.
mutation can severely increase a subject risk of being a centenarian, but
the wild-type will not increase in the same way its risk of being a control.
To convince yourself of this last point, think of the following example: we
have a random population perfectly splitted in half between healthy and
diseased. Healthy people only have the A allele at a given locus, while sick
people have both A and B. If I observe B, I’m almost sure that the subject
has the disease but, if the subject has A, I’m unable to clearly predict its
status.
Switching to nucleotides, Figure 27 on the facing page represent the nu-
cleotide counterpart of the first plot we had for AA, the biggest difference
being that here also non coding parts of the mitochondrial DNA, such as
the Dloop, are included. And indeed, along with the same good hits we
had for ATP6 and ND6 in the AA-based analyses, the strongest hit was this
time within the Dloop. The same trend can be seen in Figure 28 on page 72,
where mutations in the Dloop showed higher risk ratios that those detected
in the coding part of the molecule.
Finally, we designed a sort of "grandchild of the Manhattan Plot" com-
monly used in GWAS studies, using Bayes factors instead of p-values, which
is visible in Figure 29 on page 72. The advantage of this plot is that allows to
better understand the abundance of meaningful mutations within each gene,
without being hampered by the excess of information you may experience
in previous chart.
4.5.4 Multiple SNPs association - Epistasis
After testing the method to detect single SNPs associated with the longev-
ity phenotype, we focused on studying the epistatic interactions between
couples of mtDNA variants. When you evaluate single SNP associations,
you only need to consider two alternative hypotheses: the null hypothesis,
H0, that represents the absence of association, and the alternative hypothe-
sis, H1, which instead represents the presence of an association. However,
when you consider couples, the situation gets more complicated. In the eas-
iest case, you want to know if two variants interact or not, limiting yourself
again to two alternative hypotheses. But how these mutations interact? One
is dominant on the other? The two work together to give the phenotype?
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Figure 26: Bayes Factor versus Log Risk Ratio - non syn, AA level. The red and
green vertical bars visualize the first and second threshold value for Bayes
factor evaluation, where above 3 means positive strength of evidence.
Mutations falling in the red and green part of the graph are linked to
controls and long-lived, respectively.
Figure 27: Bayes Factor versus Log Odds Ratio - all, nt level. The red and green ver-
tical bars visualize the first and second threshold value for Bayes factor
evaluation, where above 3 means positive strength of evidence. Muta-
tions falling in the red and green part of the graph are linked to controls
and long-lived, respectively.
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Figure 28: Bayes Factor versus Log Risk Ratio - all, nt level. The red and green ver-
tical bars visualize the first and second threshold value for Bayes factor
evaluation, where above 3 means positive strength of evidence. Muta-
tions falling in the red and green part of the graph are linked to controls
and long-lived, respectively.
Figure 29: Manhattan plot based on Bayes Factor values - all, nt level. Mutations are
colored accordingly to the genes they belong to.
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After careful thinking, we built a list of 17 different possible interaction
models, all which you can see in Table 7 on the next page. The four central
columns describe the four different states in which the two loci can exist,
where W stand for wildtype and M for mutated. The coefficients starting
with an " f " are representations of the functionality level of the biological
system - possibly the pathway - in each situation. In the null model, for
example, we always have f 0, since mutations are not related to the pheno-
type under analysis. In the fourth model, "Interactions only", the system
is affected only when both the mutations are present, hence the " f 1" in the
"M1M2" column. A possible explanation of each model is given in the last
column of the table.
To study how variants interacts, we need to test all these models for each
possible couple and obtain a probability for each of them. Nonetheless,
what we really were looking for are Bayes factors, which are defined as the
ratio between two models probabilities. We thus need to choose a "base"
model against which all other models will be compared to obtain a set of
comparable Bayes factors. Given these premises, the null model, where
variants are not related to the phenotype, represents the wisest candidate
for obvious reasons. After fitting all the models on a given couple, we pick
the one with the highest Bayes factor, which will be the model that better
fits the mutations distribution in the recruited samples.
How are we sure that the best model will have the highest Bayes Fac-
tor? This boils down to the Occam’s razor principle, named after William
of Ockham, an English Franciscan friar and theologian (1287 – 1347), which
states that "Plurality must never be posited without necessity". That is, it is use-
less (and less powerful) to explain a phenomena with a model with more
parameters than required. Let’s see how this concept applies to our case
with an example. Suppose we’re analyzing a couple that is irrelevant for
the phenotype of interest: the best match in our list of models would be the
"Null model". However, also the "Complete interaction" model may fit the
problem: we have four distinct parameters in there, but nothing prevents
f 0 = f 1 = f 2 = f 3. Both models will thus fit the problem, but the first
one will have a much higher likelihood, since it must estimate only a single
parameter instead of four based on the same source dataset. Higher likeli-
hood means higher probability, which in turns means higher Bayes factor.
Since we grade our models based on this last parameter, we will eventually
choose the "Null model" as our best guess of the phenomena we’re observ-
ing, which is the correct outcome.
Result for the couple-based analysis are reported in Table 8 on page 76,
based on the analysis of all the couples composed by AA variants but ex-
cluding those positions in which we observed more than two different AA.
Indeed, the list of models obtaining a Bayes Factor greater than 3, the thresh-
old we adopted in the previous analysis considering the effect single SNPs
have on the phenotype, was much longer. Anyhow, due to the innate greater
complexity in this analysis compared to the previous one, we decided to be
more restrictive adopting a threshold of 10. The dataset we used to per-
form this analysis was based on AA variants, encoded in a binary form (0:
wildtype, 1: mutated). This helped us in keeping low the computational
burden of the process, while providing meaningful results, since mutations
causing a change in the AA chain, compared to synonymous variants, are
much easier to reconcile to a true biological process.
As you may see from the Table, some of the couples reach very high Bayes
factors. The couple ATP6_60 – ND1_17 (where _60 and _17 indicate the mu-
tated position in the AA chain) reaches a Bayes factor as high as 191 where,
according to Kass’ table for Bayes factor interpretation, a value greater than
150 suggests a "Very strong" evidence. "Strong" evidence is instead what we
got for couples ATP6_60 – ND5_159, ATP6_60 – CYB_7, CYB_158 – CYB_16
and ATP6_90 – ND2_119, albeit with progressively lower Bayes factors. For
comparison, the higher Bayes factors we obtained in the single variants anal-
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ysis were around 3 to 14. Regarding Risk Factors, we obtained values much
lower than those we reached in the single variant analysis, with a maximum
of 1.724 and a minimum of - 1.520. However, this may be due to the relative
smallness of the dataset, since bayesian approaches tend to underestimate
Risk Factors in these cases.
The obvious prosecution of the analysis plan would be to extend the test-
ing to nuclear variants, shining light on the highly debated cross-talk be-
tween the two genomes. As detailed in Materials & Methods, we indeed
have genotyping data coming from a OmniExpress chip of which we up-
dated the annotation thanks to the Ensembl APIs. However, both the setup
of the analysis and the annotation updates took more than expected, and it
wasn’t possible to complete the needed tests in due time to be included in
this thesis. This analysis will thus be the subject of succeeding studies.
4.6 ion torrent data analysis, an excursusof
Next Generation sequencing represents the new frontier in biology. Most of
the problems that were until some years ago difficult even to think of, are
now at hand. The other side of the coin is the amount of data these methods
produce and the skills needed to understand, process and analyze them,
along with the computational resources required to store and elaborate the
information.
Even if my thesis was mainly focused on different topics, the acquisi-
tion of a Ion Torrent PGMTM platform (Life Technologies, Thermo Fisher
Scientific Inc.) made by a laboratory with which we had long-standing
collaborations offered me the occasion to play with the data produced by
the sequencer. There was no need to develop new algorithms: the enor-
mous adoption these approaches are experiencing draw the attention of
very skilled developers and institution on the field, resulting in many ready-
to-use suites and programs. Our goal was thus to glue these resources
together to create a new pipeline, possibly based on open source software,
able to successfully analyze mitochondrial DNA runs, which were at that
time poorly supported by the proprietary suite, ultimately leading to below
average variants calling.
Being honest, we didn’t started from scratch: we consciously avoided to
perform the alignment step afraid of the time and resources needed to do it,
preferring to use the contigs assembled by the Life Technologies suite. This
fear later proved to be wrong, and we expanded our pipeline to comprise
also the alignment step, accomplished with BWA (H. Li et al. 2009a), but this
implementation is so young that will not be discussed here. For building
our pipeline we draw fully from GATK documentation, in particular from
GATK Best Practices (Van der Auwera et al. 2013), and assembled each
step in a seamless Python script that, given a set of bam files, process them
until the very last step, variant calling (that is not the very last step, as we
will see).
Which is the first step, then? Removing duplicates. During the sequenc-
ing process, the same DNA molecule may be sequenced many times and
these duplicate reads shouldn’t be used as additional evidence in calling
variants. This step can be easily done with the help of Picard, a java library
developed by the Broad Institute, which has the handy "MarkDuplicates"
function. Most of the NGS data management and processing is exactly like
this: a long list of commands to be repeated indefinitely, from here the ne-
cessity of an automatic solution. The glue that in our implementation holds
everything together is made by Python, leveraging the library Plumbum
(described in 3.2.2) to launch commands and interact with the system to
monitor their execution.
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Back to our pipeline, then. Next step down the line is indexing. GATK
requires a index file to lower the time it spends looking for reads inside
the bam file, which usually comes with the ".bai" extension. After flagging
duplicates, it is mandatory to rebuild the index since the bam is changed.
The next step is probably the most troublesome for mitochondrial DNA:
indel realignment. When the mapper aligns the reads to the reference, it
can produce artifacts in the close proximity of INDELs that may appear
to support the existence of several SNPs. Performing a local realignment
usually solves the problem, and GATK provides the functionalities to do it.
Problem is, GATK realigns indels on the left side, while for historical reason
some of the mtDNA variants are usually reported in their right-aligned form.
There’s no solution to this: the local realignment step is not mandatory, but
greatly improves the performance of the calling around and on INDELs,
and must thus be done. The downside is that in this way the operator that
will evaluate the called variants down the line should remember this issue
and fix the files accordingly, or a custom script must be developed to apply
the needed changes automatically.
Next up, base quality recalibration. Base qualities are values provided
by sequencers that represent how confident they are in the nucleotide they
have called (please note, base calling is not variant calling at all!). These val-
ues are often affected by systematic errors, and should be adjusted. GATK
solves the problem using machine learning techniques to model these er-
rors empirically and fix the quality values accordingly. Also this step has an
important impact on the final outcome, and is highly recommended. This
single step requires 3 to 5 different commands, still of the idea that the
"manual way" is the way to go?
We’re almost there: Variant Calling. GATK is a fairly advanced piece of
software, which can take advantage of the know variability to improve the
quality of newly called variants, delivering much better results as you will
see in a moment. In our pipeline, mitochondrial DNA variants genotyped in
the 1000Genomes project are used to help GATK in doing its job. If available,
more than one variability source can be specified. GATK provides two dif-
ferent callers: UnifiedGenotyper and HaplotypeCaller, where the latter is a
newly implemented version that fixes many of the glitches the UnifiedGeno-
typer suffered of, but doesn’t support organisms that are not diploid, and
mtDNA has a ploidy of 1. This forced us to adopt UnifiedGenotyper in our
pipeline, in spite of all the improvements available in HaplotypeCaller.
As said before, there’s still a step to do after calling, which is variant
filtering. Callers are usually really generous in calling variants to achieve a
higher sensitivity, and GATK is no exception to this rule. It is thus important
to filter variants according to different parameters to reduce the amount of
false positives. However, filtering cannot be applied to SNPs and INDELs at
the same time: they must be splitted first. Again, GATK helps us providing
the needed commands. Once filters are applied, you’re free to merge back
the variants in a single file. But what these filters are? Here’s an example of
"standard filters" for mtDNA SNPs:
1 "QD < 2.0";"QualityByDept"
2 "MQ < 40.0";"RMSMapQual"
3 "FS < 60.0";"FisherStrandBias"
4 "HaplotypeScore > 13.0";"HaploScore"
5 "MQRankSum < -12.5";"MQRankSum"
6 "ReadPosRankSum < -8.0";"ReadPosRankSum"
GATK, when filtering variants, will check each of these indexes (the first
string on the left, i.e. QD) to check if some of the variants match the filter.
If yes, the mutation is flagged with the filter name, the string between "", to
be later analyzed and possibly removed.
GATK also provides Variant Quality Score Recalibration (VSQR), which uses
the same machine learning based approach exploited in the base quality re-
calibration step to recalibrate the quality value of each called variant. How-
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ever, this technique requires huge quantities of high quality data to work,
a resource that we didn’t (and don’t) have. As a final remark in this quick
discussion about variants calling in NGS, please note that GATK documen-
tation suggests to call more samples simultaneously to improve the result.
The rationale is that in this way the caller will use variants coming from all
the samples to weight if a given variant do exists or represent a sequencing
artifact. Albeit this may prove to be helpful, the aim of our pipeline was
to give a mean of rapidly analyze many samples at once, and not perfectly
calling each single variant. A batch calling can be possibly done when all
sequences are available, but is not a procedure you should do on a daily
basis.
How our pipeline behaves compared to the stock one? Before answering
this question, we must do a preamble: the test runs we had from the lab
were from 4 different chips, with the samples in the first mapped against
rCRS, while the others were mapped against RSRS. Additionally, for the
rCRS-mapped samples we also had Sanger sequencing data to compare
them with, thus basing our consideration on a more solid reference point.
Table 9 on the next page shows the results for the 8 samples in the first
chip. Starting from SNPs and taking Sanger as the golden standard, the
vast majority of them are detected by all three methods, as visible in row
"Ion/Sanger/GATK". Ion Variant caller seems to detect more SNPs than
GATK, but manually verifying the reads all those variants doesn’t have
enough evidence to be reliably identified. GATK, on the contrary, doesn’t
recognize any additional SNP other than those in common with Sanger, pro-
viding a more reliable result. Forcing GATK to call even dubious positions,
variants identified by Sanger missing in GATK output do get called, but
with a quality so low to be immediately filtered out in normal conditions.
From these initial results, it may seem that both NGS pipelines are not up
to rival with Sanger, but there are two consideration to be done: first of
all, data from this table derive from a first test chip that suffered from se-
vere oscillations in the coverage along the molecule, reaching peaks as low
as 1 or 2 and, in fact, this is the reason why both callers refused to call
some of the variants. Secondly, we went back to the original Sanger data
to double check if variants missing in NGS outputs were well supported by
Sanger reads. The results was that even in Sanger a trained operator had
to manually evaluate the chromatograms to call those variants. Moving to
INDELs calls, and again keeping Sanger as the reference point, we observed
quite disappointing results for the Ion caller, which failed to call all Sanger
variants with the notable exception of 8281_8289del, which identifies haplo-
group B. On top of this poor result, Ion also detected non-existent mutations,
as reported in the table. On the contrary, GATK correctly identified all the
INDELs detected in Sanger, incurring in a single false positive in Sample 2,
probably due to a poly-c stretch occurring a couple of base pairs upstream.
Again, our pipeline outperformed Ion stock caller both in sensitivity and
specificity, delivering more accurate results.
Table 10 on the facing page reports the results for the same comparison
performed on 12 additional samples, of which we unfortunately didn’t have
Sanger data. Drawing definitive conclusions from this second batch is much
more difficult, since we miss a reliable reference point to compare with,
but we partially solved this lack manually checking the contigs were the
two methods were discordant. Starting from SNPs, we can observe how
also in this case the vast majority of them are called by both pipelines. As
seen in the previous comparison, Ion seems to call more SNPs than our
custom pipeline, but pays this sensitivity in terms of specificity: manually
checking the raw data there was no evidence for ~90% of the calls Ion did.
In this second comparison, also GATK performances lowered significantly,
ending up with a considerably higher number of false positives. INDELs
calls done by Ion suffered from the very same issues we saw earlier: it misses
most of the real variants (8281_8289del, instead, is correctly detected), and
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Table 9: Comparison of variants detected by Sanger sequencing, Ion Torrent variant
caller and GATK (against rCRS)
Samples
SNPs 1 2 3 4 5 6 7 8
Sanger 42 46 30 31 32 40 33 39
Ion/Sanger/GATK 35 43 27 28 32 40 33 38
Additional in Ion 0 0 4 3 1 0 0 3
Additional in GATK 0 0 0 0 0 0 0 0
INDELs
Sanger 3 4 1 2 1 2 2 2
Wrong in Iona 3 5 3 1 2 1 0 0
Wrong in GATKb 0 1 0 0 0 0 0 0
a Fails to call Sanger INDELs, with exception of 8281_8289del.
b Calls all the INDELs identified by Sanger sequencing.
Table 10: Comparison of variants detected by Ion Torrent variant caller and GATK
(against RSRS)
Samples
SNPs 1 2 3 4 5 6 7 8 9 10 11 12
Ion/GATK 43 39 49 51 45 53 55 52 54 41 40 42
Called by Ion 6 9 6 4 2 3 4 3 7 14 10 3
Called by GATK 0 1 1 1 7 3 2 0 2 !0! 0 0
INDELs
Called by Ion 0 2 4 3 0 1 5 3 2 3 4 4
Called by GATK 6 5 6 13 9 10 5 10 7 5 8 7
suffers from many false positives. Our pipeline, on the contrary, managed
to identify most of the real INDELs, but with a slightly higher level of false
positives if compared to the previous test. Summing up, Ion caller seems to
struggle quite a lot also in this second batch with both SNPs and INDELs,
while GATK performance seems to decrease, in particular for SNPs. There’s
a reason behind this behavior? In fact, there is. Analyzing this second batch
we were forced not to use the know variability to help GATK calling the
variants. The motivation is quite simple: all the variability detected by the
1000Genomes project is mapped against rCRS, not RSRS. As there is no
easy automatic way to remap these data, we disabled this feature. From the
effect this had on the results, you can pretty well understand how much
this affects the pipeline. We’re working to remap the variants against this
new reference, but the work is still underway at the moment of writing this
thesis. INDELs doesn’t seems to affected by this problem probably because
they represent only a very small fraction of the variants identified in the
1000Genomes project, and thus GATK doesn’t have enough data to improve
their calling anyway.
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5.1 the systems biology challenges
Providing answers to the challenges science is facing in the last years re-
quires an important shift from a "single mechanism" rationale to a systems
biology approach, which pervasively analyze biological entities in their en-
tirety, modeling both the inner workings of each biological system and the
interactions between them. Phenomena such as inflammaging (Cevenini
et al. 2013; Franceschi et al. 2000, 2007b) must be engaged in this way to
obtain meaningful and reproducible results, as postulated in Calçada et al.
2014. However, allow these approaches to unleash all their power requires
a considerable amount of clean data to work with. Thus, the first step in
a successful modeling attempt should be to obtain high quality datasets to
base the analysis upon.
A possible answer to this requirement are well-managed clinical and non-
clinical studies, which serve as an extraordinary source of data proxying the
functionality levels of many biological systems. NU-AGE (Berendsen et al.
2014; Santoro et al. 2014), a FP7 European project focused on contrasting
inflammaging via a 1-year diet intervention, is a good candidate to act as
data source for system biology approaches. In fact, the project aims to collect
data about many different fields (i.e. physical and cognitive status, socio-
economics indexes) and couple them with cutting-edge omics analyses (i.e.
genomics, lipidomics, metabolomics).
A second, somewhat explosive, source of data is represented by Next
Generation Sequencing. Techniques such as NGS-based epigenetic studies
(Meaburn et al. 2012) and RNA-seq, which is able to give a holistic view
of the whole transcriptome, have freed sequencing from the long-standing
limitations of being restricted to only a part of the life equation, genetics.
Research can now obtain gigabytes of data (or tens of genomes, if you pre-
fer) in a matter of weeks, not years, thus making possible to design studies
that were not even thinkable before this revolution occurred. Ion Torrent,
a NGS approach based on the ion discharge that occurs when a dNTP is
incorporated into a growing DNA strand, concurs in this very active and
competitive arena with a very high sequencing speed and low upfront and
operating costs (Merriman et al. 2012). Recently, this platform was also
applied in epigenetic studies (Cheng et al. 2013; Corley et al. 2015).
As we said in previous chapters, the very final goal of systems biology is
building models, possibly mechanistic, to explain the biological phenomena
under analysis. Important efforts have been done in this sense in the inflam-
maging field, with the modeling of the NF-κB pathway (Basak et al. 2012;
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Tieri et al. 2012) representing one of the best examples. Inflammaging, as
the term says, is related to aging: it represents a low-level chronic inflam-
mation common in elderly people, which is established during the aging
process. Aging is also linked to the loss of metabolic flexibility (DiPietro
2010; Galgani et al. 2008), that may ultimately led via multiple pathways
to the insurgence of pathological states such as type-2 diabetes (Corpeleijn
et al. 2009; Ponugoti et al. 2012). Eventually, the last link needed to close
this very long chain is made by the fact that immune response itself may be
impaired by macronutrients deficiencies (Hotamisligil et al. 2008), provid-
ing the soil on which inflammaging may sprout. Hopefully, the NU-AGE
project will help disentangling these very complex interactions with its un-
matched high-quality database.
5.2 the nu-age study
NU-AGE enrolled a total of 1250 free living subjects in the age range be-
tween 65 and 79 years old in 5 different European countries, equally subdi-
vided in males and females. After an initial characterization, subjects were
randomly assigned to one of the two branches constituting the study: diet
and controls. Subjects in the first branch followed a 1-year long diet inter-
vention, based on a Mediterranean fortified diet tailored on the elderly’s
needs, while controls subjects were only recontacted after 12 months for
the follow-up without providing them any specific nutritional advice. Each
participant was deeply characterized by mean of five standardized question-
naires (encompassing dietary habits, life-style, physical activity, health and
functional cognitive status) and, through the collection of blood, urine and
faecal samples, with omic and non-omic analyses.
5.2.1 Data management
Given the complexity of the study, is it easy to understand the pressure un-
der which the data collection process was carried out. Errors at the data
entry step cause difficult to solve problems at the database level. For this
reason, in NU-AGE we aggressively fought errors from the very first mo-
ment acting at many different levels, a detailed description of which you
can find in the Result chapter of this thesis. Briefly, we designed a data
entry interface to provide on-the-fly correction of the data and, where strict
rules could not be applied due to the innate variability biological entities
have, we proceeded validating the values analyzing their distributions at T0
and reporting suspicious outliers. Eventually, we defined strict boundaries
using as limits the 5th and 95th percentiles of the distribution.
To overcome the limitations the software we based our interface upon had
(Epidata Entry v3.1), we implemented from scratch a Python-based pipeline
to automatically perform data validation and error reporting, with a built-
in management of false positives. An additional benefit our solution has is
the possibility of leverage Python capabilities to build complex validation
rules that are out of the scope of the previously available interfaces. Even if
the inner workings of NU-AGE Validator may result too complex to under-
stand for people lacking a computer science background, the whole suite is
built with reusability in mind. Questionnaires and checks defined follow-
ing the EpiData Entry 3.1 version of the format can be seamlessly loaded in
our system, whereas new CRFs can easily be defined exploiting the YAML
format.
The very last point I would like to discuss here regarding the data entry
process, but which also pertains to the best practices for data management,
is variables documentation. This is probably the tenth time we run across
this concept, but I really believe that it represents a fundamental achieve-
ment each project must aim to. The data "half-life" is much longer than
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the duration of the project that generated them, but require an additional
effort to ensure it reaches the maximum lifespan. This "additional effort" is
indeed documenting them. We’re not talking of some exoteric who-knows-
which-format file to be manually crafted. The documentation for the whole
NU-AGE is contained in a single Excel file, which can be easily shared and
accessed by people looking for the description of what each dataset contains.
In our case, building this file was extremely easy thanks to the parsers avail-
able in Validator, but the process should not represent a huge pain in all the
projects were data entry was powered by a data entry interface. Drawing
from our direct experience, documentation started helping us even before
the database official opening for queries: researcher participating in the
project are now scrutinizing it to understand the variables they need to an-
swer to their own scientific questions, and will be ready to provide us a list
of them as soon as the data will go live, reducing dead times. This approach
also eases the workload on the data management team: providing the right
data to a group asking for variables A, B and C is much more easier than
providing data for a generic "cognitive status".
No official statistics was maintained regarding the number of fixed errors
thanks to this multi-leveled approach. Obviously, we can’t track the number
of alerts each Epidata deployment has issued until now. At the same time,
Validator was not thought to provide this kind of feedback, being focused
on a single complex task: driving out errors. However, we can state that sev-
eral systematic errors were detected and solved thanks to Validator, along
with a plethora of individual inconsistencies scattered among all question-
naires and centers, most of them caused by erroneous indexes calculations.
Also, the approach we described for continuous variables, albeit simplistic,
helped us in realizing that a more extensive comparison work had to be
carried out to make the nutrients data produced by each centre compara-
ble. This initial consideration allowed us to track inconsistencies that, to be
fixed, required to get back to the software houses that originally developed
the softwares used by the dietitians to estimate the nutrients intake. Even-
tually, this gave life to an important comparison work between the different
national guidelines that will be surely helpful to forthcoming projects and
to better shape possible european-wide efforts to act on diet as a mean of
improving health, such as those requested by the EU commission in the
framework of Horizon 2020.
5.2.2 Preliminary data analysis
Moving on in our discussion, we can now explore which information we
already got from NU-AGE. As previously said, the data entry process is
still underway, and the database, especially regarding T1 data, is far from
being complete. However, datasets regarding T0 already provided a wealth
of data that was worth to explore. The main result we had from these pre-
liminary analyses was that a custom-made compliance index to evaluate
subjects was required to better understand the project outcomes. This con-
sideration mainly moved from the PCA analysis we did on the nutrients
data gathered at T0, from which we understood that the relative positioning
of participants diet in respect to the NU-AGE diet was much more complex
than we expected. At a first glance, the analysis of the first four compo-
nents we saw in the Results section may seem discouraging, given the fact
that most participants seems to have a diet that pretty much matches the
NU-AGE one already. However, combining the first three components in
the 3D scatterplot we presented in the previous chapter, it should be clear
that the real picture is more complex than that: a subject presenting a value
for the first component very similar to the "optimal value" may at the same
time have a much worse value for the second and the third components. I
really believe that the title with which we presented the 3D scatterplot, "The
NU-AGE Cloud", represents the best definition of the situation we’re facing:
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a complex yet impalpable net formed by several interplaying parameters.
Nonetheless, result from omics and non-omics assays must be weighted by
this net of parameters: if a conspicuous number of people enrolled in the
diet branch didn’t followed the diet we are at risk of drawing the wrong
conclusions. This is the reason why UNIBO, in strict collaboration with
many of the partners involved in the nutritional trial, started investigating
the possibility of creating an index able to condense in a single number the
aforementioned net, making weighting NU-AGE results a reality. The ra-
tionale we proposed is indeed rather simple: we previously introduced the
concept of defining a diet as a point in a n-dimensional space, where n is
the number of nutrients dietitians monitor in the subjects. In a similar way,
the point representing the NU-AGE diet can be determined in the same
space. Then, computing even a simple euclidean distance between these
two points would give us a first coarse index to work with. Nonetheless,
this is a rather simplistic view of the problem. Different nutrients do have a
different importance in determining a person health, and should thus count
more in our index. At the same time, most of them are not symmetrical: be-
ing over or under the threshold for sodium doesn’t affect the system at the
same way. NU-AGE consortia is still working on solving these issues, which
require a careful revision of both the literature and the already available nu-
tritional indexes to identify clear answers to the aforementioned problems.
Nonetheless, once obtained, it will change the rules of the game, allowing
us to carefully estimate each subject position in respect to the target diet.
This will help us in better determining the NU-AGE cloud, but will also
offer an additional advantage in terms of subjects tracking. Indeed, the very
important information we want to have is not the starting or ending point
of each participant, but their trajectories in the nutritional space (Calçada
et al. 2014). Subject enrolled in the intervention branch were requested to
fill a 7-days food record at T0 and T1 and a 3-days food record at months 4
and 8, while control subjects filled only the 7-days food record at T0 and T1.
These data allow us to have a clear picture of their nutrient intakes and to
compute a compliance index for each timepoint, thus following the subjects
trajectory in time. It is clear that a diet subject is expected to move towards
the diet as time goes by, if even by a little amount, while controls should at
maximum circle around a fixed point. Any deviations from these trajecto-
ries will suggest that the data we gathered from deviating subjects should
be weighted differently from the others. In this way, we elegantly resolve all
the "bad news" we had from PCA analysis: we don’t care any longer of the
single point, being it at the T0 or T1, but we’ll evaluate our subjects on their
whole "voyage". Moreover, if this index will prove itself reliable, it may even
be adopted to guide diet interventions based on the NU-AGE diet aimed
to reduce, or even prevent, the inflammaging state, thus providing people
with additional healthy years, as Horizon 2020 mandates.
Independently from the amount of work we, together with all NU-AGE
partners, already carried out, the data analysis is still at the beginning, with
many challenging tasks yet to come. What I personally tried to achieve
with my work on this project was laying solid foundations on which anal-
yses, such as those based on multiplex networks (Menichetti et al. 2014;
Sugihara et al. 2012), can be safely designed and carried on.
5.3 the geha project
NU-AGE wasn’t the only topic on which my work was focused on. If for
this first project most of my efforts went to planning a solid data manage-
ment pipeline, I had a chance of touching also the data analysis part, thanks
to the data gathered by the GEHA project. GEHA (Franceschi et al. 2007a;
Skytthe et al. 2011) enrolled 2650 long-lived 90+ sib pairs and 2650 younger,
ethnically matched controls from 11 European countries. Out of the more
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than 2500 participants, the project successfully sequenced the whole mtDNA
molecule in 1292 samples, mainly coming from Finland and Denmark. Se-
quencing was carried out in Bologna for a small subset of the sequences,
while the majority of them were processed by the BGI (China). This splitted
source was the main cause of the first problem we had to solve even before
starting to analyze the data. In fact, routinely performed quality checks, car-
ried out following guidelines suggested by the literature (Salas et al. 2005),
detected how sequences obtained in China were of a clearly lower quality,
harboring an anomalously higher number of mutations that expected. This
fact suggested us that something may have gone wrong in the sequencing
or in the assembling step. Since raw data were available, we decided to re-
build the sequences from scratch to attempt their recovery. We rapidly built
a short but effective pipeline based on Phred, Phrap and Consed (Ewing
et al. 1998a,b; Gordon et al. 1998) and reanalyzed the data. The result was
quite positive for the vast majority of the samples, with the whole sequence
obtained right at the first attempt. However, to successfully reconstruct a
small set of lower quality samples, we had to lower the pipeline strictness
in quality terms. In this way, we managed to retrieve the whole sequences,
at the cost of relying on the human intervention to fix errors due to previ-
ously excluded low-quality reads. This work allowed to detect, comparing
the batch of sequences assembled in China to the one obtained by us, ~700
errors mainly clustered around homopolymer stretches. It is unquestion-
able that, albeit extremely time-consuming, this effort severely increased
the quality of the dataset, providing more consistent data to propel the fol-
lowing analyses.
5.3.1 Background and methods setup
In 2014, Raule at al. delivered some insight of the initial analyses on the
GEHA mtDNA sequences, where the main outcome was represented by the
fact that no single mutation was found associated with the longevity phe-
notype. Nonetheless, when considering the relative abundance of non syn-
onymous variants within subunits forming the OXPHOS complexes, statis-
tical significant associations appeared for subunits composing the OXPHOS
complexes I, III and V. This suggested us to further analyze the sequences
from an epistasis perspective. Literature was already generous in describing
methods to detect epistatic effects (Cordell 2002; Emily 2012; Moore 2015;
Moore et al. 2014; Ritchie 2015) but, since we realized that none of them
was able to fully exploit the datasets we had, we focused on developing new,
more powerful approaches. The first candidate we tested was entropy analy-
sis, as defined by Shannon 2001. Results, as previously shown, did allow us
to detect interactions among variants, but the approach somewhat lacked in
answering to our original question: the probability of a subject being long-lived
given a signature of interacting mutation. We thus decided to follow a differ-
ent approach, based on Bayesian statistics. Initially, we tested this method
to detect single SNPs associated to long-lived subjects and, in doing so, we
analyzed two possible representations of the data: from an AA point of
view, in which only non-synonymous mutations are considered, and from
a nucleotide point of view, where all variants, even synonymous ones, are
taken into account. Obviously, the former representation do provide results
that are more readily understandable: non-syn mutations change an AA in
the polypeptide chain, which in turn can hamper the protein functionality.
On the contrary, explanations for a change in risk ratios caused by synony-
mous mutations are harder to give. Still, for variants occurring within gene
boundaries, theories about the codon bias and the different processivity of
different tRNA may provide an explanation (Camiolo et al. 2012; W. Jia et
al. 2008; Tats et al. 2008). The biological effect for variants in non-coding re-
gions, instead, should be sought in their regulatory function, i.e. the Dloop
involvement in the mtDNA replication (Wallace 2005).
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5.3.2 Single variants association
We first tested the method looking for singularly associated variants, with-
out taking epistasis interactions into consideration. Results for our AA-
based analysis were encouraging, since our algorithm was able to grasp
associations that were overlooked by previous analyses. In particular, we ob-
tained significant Bayes factors (BF) for mutations harbored in ATP6, ND6,
Cytochrome B and various other subunits. This finding, in contrast with
the conclusions in Raule et al. 2014, suggests that single non-syn mutations
are indeed involved in shaping the longevity phenotype, with log risk ratio
(RR) as relevant as 3.5 and -3.6, meaning a 33-fold increase and a 35-fold
decrease in the risk of not being long-lived, respectively. It is important to
note that log Risk Ratios are relative risks: given the very low probability in
the general population, the absolute risk is much lower. Similar results were
obtained considering the nucleotide-based representation of our datasets, in
which all results previously obtained at the AA level were confirmed at the
nucleotide level. Nonetheless, the strongest hit was due to the Dloop, with
a Bayes factor of 16.5 and a log risk ratio of 3.77 (43-fold increase). This
additional discovery allow us to postulate that also the non-coding parts of
the mtDNA molecule do play a role in determining the longevity pheno-
type. In spite of this promising results, due to the fact that the method was
first thought to evaluate only epistatic interactions, we need to consider the
effect linkage disequilibrium, which is particularly strong in the mitochon-
drial DNA due to the lack of recombination, may have in the analyses. We’re
not saying that these results are inconsistent, but that the relative abundance
of the found associated variants may partly be due to mutations that are in
linkage: this would cause to detect as associated to the phenotype variants
that are only in strong linkage with a mutation associated to the phenotype.
Another critical point is represented by the fact that the mutation rate is
not uniform on the whole molecule: Dloop has a much higher rate than
the coding part, and mutational hotspots such as HV1 and HV2 mutate
even more (Stoneking 2000). Given this complex panorama, the prior we
used to provide the method with an estimate of the variability expected at
each position may not be sufficient. Empirical tests we performed manu-
ally changing this prior did not caused severe oscillations in the results, but
we’re in any case planning to build a more advanced prior based on the
analysis of high-quality sequences freely available in GenBank (Benson et
al. 2013), that will solve this problem for good.
5.3.3 Multiple variants association - Epistasis
After testing and tuning the method with single variants association analy-
sis, we moved to epistasis detection. As common sense suggest, the com-
plexity of such an analysis is much greater than the previous one. Indeed,
in single associations we are comparing only two hypotheses – the variant
is associated or not – while determining the kind of interaction occurring
between two mutations requires to test more of them. After careful think-
ing and investigation, we came up with a list of 17 possible models of in-
teraction, all of which are listed in Table 7 on page 74. These models do
encompass all the ways in which two alleles may interact, ranging from
pure interaction to more complex cases in which a variant is dominant on
the other or in which the two variants singularly cause different damages
while their co-presence reconstructs the pathway. The downside of having
such a fine analysis is represented by the fact that it do produce a huge
quantity of raw data – for each couple we obtain 17 Bayes factors for the 17
models, each of which has 3 separate Risk Factors linked to three possible
allele combinations – that must be then filtered to extract the meaningful
information.
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Final results, contained in Table 8 on page 76, clearly depict a complex
panorama where multiple couples do interact and change the probability of
being long-lived. The "Complete Interaction" model for couple ATP6_60 –
ND1_17 reached a very significant Bayes Factor of 191 (150, following Kass’
interpretation table, represents the minimal threshold to claim a Bayes factor
as "Very strong") and a log risk ratio of 1.418 (4-fold increase) for the M1W2
allele combination. At the same time, combination W1M2 has little to no
effect (RR: 0.017), while log Risk Ratio for the combination M1M2 is 0.847.
The arrangement of these values suggests that, while the first mutations
is detrimental, the second doesn’t have an effect on its own but counter-
balances the damaging effect of the first mutation if they both occur. The
following couple, ATP6_60 – ND5_159 (BF: 108, RRs: 1.003, -0.481, 1.724), is
indeed better explained by a "Mutation 1, Interaction" model, in which the
first mutation has an effect on the phenotype (RR: 1.003), the second has a
very little protective effect (RRs: -0.481) but they interact together causing
a 5-fold increase in the risk of not being long-lived. This couple also offers
a second cause of reflection: in these analyses, at least in some cases, we’re
dealing with rare mutations, which occur in the general population at very
low frequencies and it is thus normal to see them in few of our subjects.
This, however, makes correctly estimating RRs a difficult task. For example,
in the just described couple we had a "control,cases" count of 3,9 for M1W2
and a count of 2,1 for W1M2. While RR estimation for the first is pretty
solid, the RR estimation for the second may suffer of overestimation. It is
important to note that model selection and RR calculation are two separate
processes, the latter being more influenced by extreme cases. In this pecu-
liarity we should look for the reason why our model selection do choose a
"Mutation 1, Interaction" instead of a "Complete Interaction", which would
better fit observed RRs. For comparison, the third couple, ATP6_60 – CYB_7,
which has stronger counts, shows a perfect match between the called model
and the RRs ("Mutation 1, Interaction", RRs: 1.327, 0.122, 1.435). The same
holds for the fourth couple (CYB_158 – CYB_16, "Concordant 2", RRs: 0.026,
1.243, 0.197). The fifth couple, ATP6_90 –ND2_119 ("Complete Interaction",
RRs: 0.003, 0.003, 1.280), gives us the possibility to discusses a second cur-
rent shortcoming of the method, on which we’re already working on. RRs
in this case are 0.003, 0.003 and 1.280, with the first and second one identical
up to the third decimal digit, pointing to a "Interaction only" model. None-
theless, the algorithm selects a "Complete Interaction" model as the best
representation for this couple behavior, since nothing prohibits f 1 = f 2
(see Table 7). We spent a bit of time trying to understand the reasons be-
hind that and we eventually found two possible explanations: the first is
attributable to the fact that for cases M1W2 and W1M2 we don’t have any
count. However, with priors we are giving to the system a vague idea of
what it should expect in terms of mutation counts in each position, and the
interplay between these priors and a zero count may in some way affect
the selection process. The second reason strictly depends from the first: if
the counts are off due to the priors or they are very low on their own, the
system struggles in deciding which is the best model, with many related
models reaching comparable Bayes factor. At the moment, the system does
not take this intrinsic indecision into account, simply choosing the highest
scoring model. We’re already working on a second iteration of the algorithm
that will address this problem acting at two different levels: first, cases with
a very low mutation count will be treated better gauging the effect priors
have on the models fitness estimation. Second, the routine that picks the
best model, which now simply takes the one with the highest Bayes factor,
will be augmented to consider also additional indexes, such as mutations
counts, Risk Ratios or other biological plausibility measurements, thus em-
powering a more wise decision that should ultimately lead in all the cases
to the selection of the simpler possible model to explain the phenomena.
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Independently from the issues just described, caused by pitfalls that are
common in newborn algorithms implementations, the method hereby de-
scribed was able to effectively analyze a massive number of candidate cou-
ples (~36000) for their effect on the longevity phenotype, possibly regulating
the inflammaging process, in a very short period of time. In fact, thanks to
the adoption of analytical methods instead of numerical methods, the time
required to analyze a single couple stands around ~0.008 seconds, which
means that only 5 minutes were required to complete the just discussed
analysis using a single processor. Moreover, since the method computes
each couple statistics independently from the others, it is easily paralleliz-
able. Once obtained, this feature will further push the limits of the method,
in term of computational scalability, onwards. A so low computational time
finally allows to think of completely exploring at least the mitochondrial
variability in matter of hours, not years. For example, GEHA detected a
total of ~2000 mutated positions at the nucleotide level in its mtDNA sam-
ples, which translates in 4 million couples to analyze. Processing them at
the actual pace would require ~9 hours (4,000,000 * 0.008 = 32000 seconds,
8,8 hours.). After the parallelization of the method, this estimate will be
severely reduced, the extent of which depending on the number of CPUs
devoted to the task. At that point, including the nuclear variability GEHA
detected in the analysis will be totally feasible. A paper describing the
strong points and the pitfalls of this statistical analysis method is in prepa-
ration.
Before concluding the discussion of GEHA results, we have three addi-
tional points to touch. The first is that it is normal that results for the single
and couple-based analyses do not overlap, since in the second case we’re
analyzing a different hypothesis. For example, when we analyze the M1W2
combination, we’re not only considering the presence of M1, but also the
absence of M2, and the same concept holds for W1M2. After all, having
out-of-expected counts for i.e. W1M2 may suggest a interaction between a
mutated and a wildtype allele, that our method will successfully recognize,
not being at all influenced by labels like "mutated" and "wildtype". Given
these premises, it is particularly striking the fact that ATP6 mutations scored
as the most longevity-associated in the single analysis and many of the best
scouring couples in the epistasis analysis do comprise ATP6. This strongly
suggests that ATP6 may play a central role in determining if a subject will
be long-lived or not. Additionally, this finding is perfectly in line with the
conclusions of Raule et al. 2014, which points to the OXPHOS complexes
as mayor players in shaping longevity.
The second point I would like to discuss is the fact that log Risk Ratios,
independently from being computed on single variants or mutation cou-
ples, can be summed to obtain the log Risk Ratio of having, for example,
two independent mutations. This consideration paves the way to the esti-
mation of the RR for a subject starting from its own mutational signature,
simply adding the single RR due to each mutation or combination of. How-
ever, given the data we have at the moment, this must be still considered
an incomplete dream: how to deal with the fact that the same mutation
may have a different RR if considered alone or in combination with another
variant, let alone if involved in higher grades interactions? Unfortunately,
our knowledge is far from being advanced enough to answer to this last
question.
The third, and last, point is about flexibility. In the context of this thesis,
we’ve always declined this method as a way to evaluate epistatic effects oc-
curring between two or more mutations. But this was just for convenience,
due to the problem we were discussing. The algorithm expects as input
a binary matrix but doesn’t make any assumption on the kind of data the
matrix itself contains. At the same time, all the models of interaction we
defined are applicable in most of the biological contexts. In practice, this
means that the very same method may be used to test more heterogeneous
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scientific questions, such as: "Do this mutation interact with high blood
pressure to give rise to cardiac problems?" or, more generally, "Do being
overweight interacts with a lower cognitive function to cause accelerated
aging?". For sure, NU-AGE will put this technique at good use: "Do this
mutation in combination with an impaired nutrients intake shape inflamma-
tion and inflammaging phenomenas?" is just one of the questions that may
find an answer with this method.
5.4 next generation sequencing data anal-ysis
Advanced approaches as the one just described usually require massive
quantities of raw data to successfully identify variants that have only small
effects on the phenotype, which indeed is the working hypothesis when
dealing with complex phenotypes. Next generation sequencing represents
the most successful attempt to provide to these methods enough fuel to run
consistently. It is indisputable that NGS completely revolutionized the way
in which researcher think about sequencing, delivering at the same time an
extremely high throughput and a consistent fall of the upfront and opera-
tive costs. During my PhD, I had the opportunity to work with one of these
machines, an Ion Torrent PGMTM platform, with the aim of implementing
a new pipeline able to autonomously perform all the steps needed to trans-
form the raw data produced by the sequencer in the final result: variant
calls. In doing so, we adopted two open source softwares, Picard and GATK
(DePristo et al. 2011; McKenna et al. 2010; Picard Website), which together
concur in providing all the instruments needed to complete all the stages
of which the variant calling process is made of. GATK developers’ team,
drawing fully from their own expertise in sequencing at the Broad Institute,
prepared a set of Best Practices (Van der Auwera et al. 2013) to follow in
most use cases, on which our pipeline is heavily inspired. As previously
explained, the "life" of variant calling is mainly constituted by repeating the
same, highly predictable, commands invoking already written algorithms.
What we thus did was making this process automatic, thanks to a program
implemented in Python that leveraged the excellent Plumbum library to
interact with the system and monitor the tasks.
A direct speed comparison between our custom pipeline and the instru-
ment manufacturer’s one is not possible, since our implementation doesn’t
include the read alignment task. There are many reason for that, the main
being the high computational requirements needed to accomplish this step.
Furthermore, successful contigs assembly is critical for obtain high quality
results, and must be double-checked by an operator before proceeding to the
next stages. This assignment is usually achieved with softwares like FastQC
(FastQC Website), which automatically compute quality indexes useful to
rapidly evaluate the contigs quality. It is thus contradictory to add a step
requiring human intervention to an automatic pipeline. However, given the
fact that most of the bad runs can be identified right from the sequencer,
and that the computational power for aligning mitochondrial reads is much
lower than we expected, we eventually added the reads alignment step in
our pipeline, but this inclusion is so recent that its benefits are still to be
assessed in the long term and thus can’t be described here.
On the contrary, a comparison of the two pipelines in terms of sensi-
tivity and sensibility in variant calling is indeed possible. As reported in
the Results section, our custom pipeline outpaced the manufacturer’s sys-
tem in calling both SNPs and INDELs. However, this difference partially
faded out when we were forced to disable the GATK feature that includes
information given by known variability in the calling of variants hosted by
new samples. This clearly demonstrates the importance broad project such
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as 1000Genomes and the open data revolution, which is infecting more and
more researchers everyday, both have in improving the daily routine of labs
all around the world. Personally, I deeply believe in both of them.
6 CONCLUS IONS
The reader, reaching this point, may ask himself, or herself, why all the
work hereby described matters with a PhD in experimental pathology. In-
deed, the whole thesis is focused on providing and analyzing data to better
understand how to counteract inflammaging and explain the longevity phe-
notype, two deeply related phenomena.
Crunching everything in a bullet list, in this work we achieved the:
• Design and implementation of a data entry interface in Epidata for the
NU-AGE study;
• Design and implementation of the database models for NU-AGE;
• Deployment of a LabKey instance for the data management needs of
NU-AGE;
• Design and implementation of a framework for data validation in clin-
ical and non-clinical projects;
• Preliminary analyses on NU-AGE nutrients data;
• Drafting of a compliance index to evaluate NU-AGE subjects nutri-
tional trajectories;
• Development of a Bayesian-based method to evaluate genetic variants
associations and their epistatic interactions;
• Development of a pipeline for Next Generation Sequencing variant
calling starting from Ion Torrent data;
Going into the details, in NU-AGE my work was to ensure that all the data
captured in the context of the project were collected with the highest possi-
ble level of standardization, hence providing a solid base on which analysis
may have been planned. Striving to reach this goal we produced a set of
high-quality tools that have the potential of being adopted in forthcoming
studies, Validator among the others for its potential to be used in other
studies. Also our Epidata-based interface, albeit suffering of the old-age
problems we already discussed, may be put at good use in certain context,
i.e. where a single center is involved in the study.
After analyzing the T0 data about the nutrients intake, we realized that
clearly understanding how to weight each subject data in function of his/her
adherence to the diet, or in function of being a good control, was a key req-
uisite to achieve the project goals. We thus started the definition of an index
to precisely estimate the diet compliance of each participant. This particular
work, unfortunately, is still in development. However, when established, it
could be used well outside the boundaries of the NU-AGE study, for exam-
ple to evaluate how a person diet relates with the diet the project defined
to help counteract inflammaging. Eventually, should NU-AGE confirms the
diet as an effective way to contrast the chronic inflammation that character-
ize the aging process, this index may acquire a significant meaning also in
pathology, given that most age-related diseases have an inflammatory base.
GEHA aim was somewhat more limited, focused solely on the genetic
components of longevity. Since previous analyses suggested that single
mutations were not enough to explain the aging process and the answer
was instead probably lying in the interaction of multiple mutations, we de-
signed a new method based on Bayesian statistics to explore the possibility
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of epistatic effects among different variants. The developed algorithm has
proved itself as a good and efficient tool to explore the association of both
single and multiple interacting mutations to the longevity phenotype. None-
theless, it suffers of all the usual youth issues every implementation has at
its first iteration. We’ll work in the future to iron these wrinkles out. As
far as the result we obtained applying this method to GEHA data, we were
able to detect single variants mutation associated with the aging process
that were overlooked by previous analyses. At the same time, we identified
several AA mutations forming couples that seems to impact on the longev-
ity phenotype. While additional checks are required before fully accepting
these results as true, i.e. checking if the two AA changes affect interacting
protein domains, from a statistical point of view they are already enough
strong by themselves.
Speed is the driving problem that dictates which analysis can or cannot
be done in reasonable time in the world of interactions evaluation, being it
a NP-hard problem. Our method takes around 7 milliseconds to evaluate
all the possible ways two mutations have to interact. This performance
make exploring the whole mitochondrial variability, at the nucleotide level,
doable in a matter of hours. Furthermore, we’re already planning to extend
the analysis to nuclear variants, finally shedding a bit of light on the nuclear-
mitochondrial crosstalk. Finally, the fact that the method does not make any
assumption on the input data allows to analyze scientific questions outside
pure genetics: in theory, evaluating if a certain mutation interacts with some
pathological state to give rise to a particular phenotype should not be a
problem anymore.
Finally, our work to define a new pipeline to process Ion Torrent raw
data eventually ended in a system that, at least for what concerns the mi-
tochondrial DNA, outperforms in the variant calling task the stock pipeline
provided by the manufacturer both in terms of specificity and sensitivity. As
for the Bayesian method cited above, also in this case we’re committed in
further improving the pipeline performances by mean of providing it high-
quality known variability data and including the contings assembly step.
This thesis, in front of several closed questions, leaves some open ones
behind. In extreme cases, it even contributed in opening some. However,
for most of them a proper solution was at least drafted. After all, that’s
how science does work. Whenever possible, all the code developed was
designed with reusability in mind, building tools that may be in future
used by different projects and individuals to tackle the same problems we
faced ourself, leaving them more time to enjoy the much more funny task
of breaking their own mind on understanding results.
Stealing from the words of Dr. Bang Wong, creative director of the Broad
Institute of MIT, a small wish for all the people that spent their time in read-
ing this 3-years extract of my life:
I hope you’ll find good things in your data!
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